Disorders of mineral metabolism

E4_MINERAL_MET

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — E83 Cause of death: ICD-10 — E83 2 out of 7 registries used, show all original rules.	4124
4. Check minimum number of events None	4124
5. Include endpoints E4_COPPER_MET E4_IRON_MET E4_ZINC_MET E4_PHOS_MET E4_MG_MET E4_CA_MET E4_MINERAL_METNAS	4204
6. Filter based on genotype QC (FinnGen only)	3712

Control definitions (FinnGen only)

Control exclude: E4_METABOLIA

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: E70-E90
Name in latin: Perturbationes metabolismi mineralium

NAME	E4_MINERAL_MET
CONTROL_EXCLUDE	E4_METABOLIA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	E4_COPPER_MET\|E4_IRON_MET\|E4_ZINC_MET\|E4_PHOS_MET\|E4_MG_MET\|E4_CA_MET\|E4_MINERAL_METNAS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	E83
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	E83
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Disorders of mineral metabolism based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	20513	11800	8560
Only index persons	17898	10452	7446
Unadjusted period prevalence (%)
Whole population	0.30	0.34	0.24
Only index persons	0.34	0.38	0.28
Median age at first event (years)
Whole population	64.04	65.92	61.47
Only index persons	63.59	65.28	61.23

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3712	2109	1603
Unadjusted period prevalence (%)	0.74	0.75	0.74
Median age at first event (years)	63.22	62.25	64.49

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3857: Matched controls
38570

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

E86

ICD-10 Finland

Volume depletion

62.2

321.0

178

E83.4

ICD-10 Finland

Disorders of magnesium metabolism

1661.4

312.6

300

E83.51

ICD-10 Finland

Hypocalcemia

849.2

307.7

909

BAA60

NOMESCO Finland

Total thyroidectomy

14.5

307.7

320

239

E21.0

ICD-10 Finland

Primary hyperparathyroidism

20.1

307.7

438

244

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

23.3

307.7

263

121

A11CC03

ATC

alfacalcidol; systemic

30.8

307.7

620

238

E83.1

ICD-10 Finland

Disorders of iron metabolism

285.6

307.7

643

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

36.0

307.7

287

BBA30

NOMESCO Finland

Excision of lesion of parathyroid gland

27.7

307.7

307

120

A12AA04

ATC

calcium carbonate; oral

23.6

307.7

297

136

106

Kela drug reimbursment

Hypoparathyroidism

161.4

307.7

199

E87.6

ICD-10 Finland

Hypokalaemia

24.9

307.7

373

165

N17.9

ICD-10 Finland

Acute renal failure, unspecified

8.9

307.7

425

528

E21.3

ICD-10 Finland

Hyperparathyroidism, unspecified

22.9

307.7

261

122

E21.09

ICD-10 Finland

Other primary hyperparathyroidism

25.8

307.7

408

176

E83.50

ICD-10 Finland

Hypercalcemia

447.7

307.7

1689

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

6.5

306.1

543

942

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

3.1

260.0

1921

9296

TPH00

NOMESCO Finland

Phlebotomy

43.6

259.8

155

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

11.9

248.3

258

231

E89.2

ICD-10 Finland

Postprocedural hypoparathyroidism

2330.7

240.0

230

BBA40

NOMESCO Finland

Subtotal parathyroidectomy

41.5

238.6

144

A11CC02

ATC

dihydrotachysterol; oral

86.9

223.8

118

C03CA01

ATC

furosemide; systemic

2.9

217.0

1543

7145

E83.58

ICD-10 Finland

Idiopathic hypercalciuria

561.2

216.4

213

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

4.7

215.6

562

1361

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

10.7

207.2

231

229

321

Kela drug reimbursment

Paricalcitol and cinacalcet

23.9

201.8

145

H05BX01

ATC

cinacalcet; oral

23.5

197.9

143

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.6

183.5

703

2237

JN4AD

NOMESCO Finland

Body CT examination

3.4

178.5

774

2662

E87.5

ICD-10 Finland

Hyperkalaemia

24.8

176.7

125

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

5.6

168.1

340

659

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.5

167.9

2214

13435

E21.2

ICD-10 Finland

Other hyperparathyroidism

34.0

166.6

106

E83.39

ICD-10 Finland

Other disorder of phosphorus metabolism

1702.0

163.7

158

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

4.5

159.3

426

1044

N18.8

ICD-10 Finland

Other chronic renal failure

8.4

158.1

211

264

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

13.1

156.1

151

120

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.8

150.2

943

3970

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.9

149.3

873

3538

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.0

149.1

772

2925

N19

ICD-10 Finland

Unspecified kidney failure

5.9

148.3

278

501

TK800

NOMESCO Finland

Hemodialysis

8.4

146.2

194

241

N02AA05

ATC

oxycodone; systemic

2.7

145.0

1008

4463

M05BX04

ATC

denosumab; parenteral

3.9

143.1

468

1327

SPAT1074

SPAT

Venesection

22.5

140.3

103

BB1BQ

NOMESCO Finland

Extensive scintigraphy of parathyroid gland, 2 isotopes, SPECT and low-dose CT

23.8

139.4

100

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.4

137.9

1399

7373

M04AA01

ATC

allopurinol; systemic

3.0

137.6

708

2664

B03XA02

ATC

darbepoetin alfa; parenteral

7.5

132.1

194

271

Z49.1

ICD-10 Finland

Extracorporeal dialysis

10.9

130.7

142

135

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

11.3

128.7

136

124

EP1AE

NOMESCO Finland

Neck ultrasound examination

4.0

128.4

399

1088

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

4.0

126.9

393

1069

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

14.7

126.5

114

D64.9

ICD-10 Finland

Anaemia, unspecified

3.1

123.7

606

2209

104

Kela drug reimbursment

Thyroid insufficiency

3.7

122.8

429

1268

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

11.9

122.5

125

108

JN3AD

NOMESCO Finland

Abdominal CT examination

2.8

121.8

723

2926

AA1AD

NOMESCO Finland

CT of head and brain

2.3

121.5

1322

7105

V03AE01

ATC

polystyrene sulfonate; oral

11.7

120.2

124

109

TPH00, ,

SPAT

29.9

119.3

127

Kela drug reimbursment

Transplant complication

9.2

117.2

144

162

H03AA01

ATC

levothyroxine sodium; systemic

2.4

116.2

1102

5565

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

12.9

115.6

112

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.1

114.4

530

1866

WW500

NOMESCO Finland

Blood transfusion

4.5

109.3

284

676

TPH04

NOMESCO Finland

Cathetrisation of vein

2.4

109.2

1006

4998

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

15.1

108.6

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

2.6

107.5

756

3315

TPX10

NOMESCO Finland

Implantation of vascular injection port

5.2

105.8

223

446

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.3

104.7

1075

5579

BBA20

NOMESCO Finland

Exploration of parathyroid gland

29.2

98.9

Z94.0

ICD-10 Finland

Kidney transplant status

10.8

98.2

107

102

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

16.7

97.9

L04AD02

ATC

tacrolimus; systemic

10.8

97.3

106

101

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.8

96.9

538

2085

Z51.5

ICD-10 Finland

Palliative care

2.9

96.2

510

1928

R53

ICD-10 Finland

Malaise and fatigue

2.2

95.0

1094

5914

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.6

94.7

643

2759

L04AA06

ATC

mycophenolic acid; systemic

6.8

94.4

150

228

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

19.6

93.9

XW000

NOMESCO Finland

Bone marrow biopsy

4.1

93.5

266

677

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

13.4

93.1

D35.1

ICD-10 Finland

Benign neoplasm: Parathyroid gland

25.4

92.9

KA1AE

NOMESCO Finland

Kidney ultrasound examination

5.3

92.9

192

377

E21.1

ICD-10 Finland

Secondary hyperparathyroidism, not elsewhere classified

34.6

91.6

A02BC02

ATC

pantoprazole; systemic

2.1

91.0

2793

21375

WZC00

NOMESCO Finland

Treatment plan or consultation

2.0

89.2

1605

10177

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.1

88.7

1119

6240

3025

Kela drug reimbursment

Calcium carbonate

17.3

88.6

ZX120

NOMESCO Finland

Intravenous

2.9

88.5

477

1815

Z49.0

ICD-10 Finland

Preparatory care for dialysis

10.8

88.4

N17.8

ICD-10 Finland

Other acute renal failure

9.0

87.9

109

124

H02AB06

ATC

prednisolone; systemic

1.9

86.8

1984

13607

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

5.3

86.5

178

348

E83.59

ICD-10 Finland

Other disorders of calcium metabolism

857.2

85.9

137

Kela drug reimbursment

Uraemia requiring dialysis

11.2

85.1

196

Kela drug reimbursment

Paricalcitol and cinacalcet

15.9

83.9

SPAT1262

SPAT

Handing over of treatment supplies

2.3

83.7

771

3780

N18.0

ICD-10 Finland

End-stage renal disease

9.9

83.3

R50.9

ICD-10 Finland

Fever, unspecified

2.3

81.6

712

3407

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

7.4

81.0

119

166

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

4.2

80.6

220

542

TPH07

NOMESCO Finland

Cathetrisation of artery

2.6

80.2

525

2201

B99

ICPC

Blood/lymph/spleen disease other

13.7

79.3

J01MA12

ATC

levofloxacin; systemic

2.2

77.7

835

4346

C08CA01

ATC

amlodipine; oral

1.9

77.6

1576

10277

WZC30

NOMESCO Finland

Teaching

2.2

76.9

790

4037

V03AE02

ATC

sevelamer; oral

14.6

76.8

R11

ICD-10 Finland

Nausea and vomiting

2.8

76.0

416

1591

C90.0

ICD-10 Finland

Multiple myeloma

7.6

76.0

108

145

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

4.6

75.9

183

409

N18.4

ICD-10 Finland

Chronic kidney disease, stage 4

10.4

75.7

A41.9

ICD-10 Finland

Sepsis, unspecified

4.1

75.7

214

541

A03FA01

ATC

metoclopramide; systemic, rectal

2.1

75.6

998

5609

BBA70

NOMESCO Finland

Implantation or transplantation of parathyroid gland

36.6

75.2

B05DB

ATC

Hypertonic solutions

12.6

74.4

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.1

74.3

956

5317

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

3.6

74.3

262

773

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.6

74.1

493

2080

V03AE03

ATC

lanthanum carbonate; oral

19.0

73.6

A10AB05

ATC

insulin aspart; parenteral

3.0

73.5

349

1234

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

15.5

73.5

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

6.7

72.3

116

178

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

6.7

71.4

114

174

H02AB09

ATC

hydrocortisone; systemic

5.2

70.5

148

294

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

8.6

69.1

106

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

7.6

69.1

134

N02AX02

ATC

tramadol; systemic, rectal

1.8

69.1

1731

11929

WF049

NOMESCO Finland

Radiotherapy of metastasis

3.6

68.9

239

697

C07AB07

ATC

bisoprolol; oral

1.8

67.9

1885

13373

205

Kela drug reimbursment

Chronic hypertension

1.9

67.6

1050

6210

A10AE04

ATC

insulin glargine; parenteral

2.7

66.7

405

1630

B05DA

ATC

Isotonic solutions

10.6

65.7

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

11.1

65.1

I50.9

ICD-10 Finland

Heart failure, unspecified

2.3

65.1

566

2686

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.0

64.9

958

5557

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.5

64.6

442

1884

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

3.7

64.6

214

605

153

Kela drug reimbursment

Lenalidomid

10.3

64.4

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

4.7

63.8

151

332

E20.9

ICD-10 Finland

Hypoparathyroidism, unspecified

115.4

63.0

WX408

NOMESCO Finland

General anesthesy, balanced

1.9

62.6

1045

6303

ZXD05

NOMESCO Finland

Urgent procedure

1.9

62.3

1139

7073

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

8.8

62.1

Z49.2

ICD-10 Finland

Other dialysis

10.2

62.0

103

Kela drug reimbursment

Diabetes, insulin-treated

1.9

60.8

1025

6195

TK810

NOMESCO Finland

Hemofiltration

13.8

60.5

R06.0

ICD-10 Finland

Dyspnoea

1.9

60.2

1088

6719

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.1

60.2

733

3961

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

3.3

60.0

241

771

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

9.5

59.9

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

12.8

59.8

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

4.5

59.7

150

346

E20.8

ICD-10 Finland

Other hypoparathyroidism

307.1

59.5

WX402

NOMESCO Finland

General anaesthesia

1.9

59.3

919

5395

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.4

59.1

222

681

L04AX04

ATC

lenalidomide; oral

9.6

58.7

H03BB01

ATC

carbimazole; oral

3.6

58.4

200

578

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

13.7

57.9

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

3.3

57.0

220

686

E55.9

ICD-10 Finland

Vitamin D deficiency, unspecified

10.0

56.9

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

6.5

56.2

144

B01AB10

ATC

tinzaparin; parenteral

2.2

55.9

507

2439

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

3.0

55.9

253

868

A04AA01

ATC

ondansetron; systemic, rectal

2.4

55.9

408

1787

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

55.7

933

5602

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

55.5

1630

11535

UJF32

NOMESCO Finland

Coloscopy

1.8

55.4

1072

6732

J01MA02

ATC

ciprofloxacin; systemic

1.7

54.7

1508

10474

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

3.6

54.7

183

520

E83.9

ICD-10 Finland

Disorder of mineral metabolism, unspecified

+∞

54.3

R4190

NOMESCO Finland

Nutritional therapy

3.4

54.1

206

637

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.1

54.0

584

3009

E21

ICD-10 Finland

Hyperparathyroidism and other disorders of parathyroid gland

20.7

54.0

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.8

54.0

289

1087

329

Kela drug reimbursment

Lenalidomide

10.9

54.0

E05.0

ICD-10 Finland

Thyrotoxicosis with diffuse goitre

4.4

53.8

139

328

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

5.0

53.7

117

240

D44.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Thyroid gland

5.8

53.6

175

I10

ICD-10 Finland

Essential (primary) hypertension

1.7

53.5

2315

18098

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

11.6

53.4

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

18.1

53.4

KH1AD

NOMESCO Finland

CT of urinary organs

3.4

52.4

199

614

N16.3*E83.50

ICD-10 Finland

Nefrocalcinosis NEC

269.5

52.2

A10BH05

ATC

linagliptin; oral

3.1

51.2

227

769

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

15.9

51.2

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

5.0

51.1

111

227

WW200

NOMESCO Finland

Immunization

4.0

50.5

146

375

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

3.7

50.0

163

455

B03XA01

ATC

erythropoietin; parenteral

7.8

49.3

M10.9

ICD-10 Finland

Gout, unspecified

2.6

49.2

309

1259

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.1

49.1

518

2637

E61.2

ICD-10 Finland

Magnesium deficiency

107.5

48.9

C03DA01

ATC

spironolactone; oral

2.1

48.9

489

2440

GD1AD

NOMESCO Finland

Thorax CT examination

2.5

48.8

316

1306

E78.29

ICD-10 Finland

Other mixed hyperlipidaemia

15.7

48.6

JN4BD

NOMESCO Finland

Extensive body CT

2.2

48.3

461

2257

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.1

48.3

215

730

A10AC01

ATC

insulin (human); parenteral

2.6

48.2

294

1180

A06AD11

ATC

lactulose; oral

2.0

48.0

597

3227

M14.5*E83.1

ICD-10 Finland

Arthropathy in haemochromatosis

+∞

48.0

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

16.8

47.9

N02BE01

ATC

paracetamol; systemic, rectal

2.1

47.3

3440

30619

A12AA06

ATC

calcium lactate gluconate; oral

68.3

47.2

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.4

47.1

351

1548

L28

ICPC

Limited function/disability (L)

1.9

47.0

774

4591

H02AB02

ATC

dexamethasone; systemic

2.1

47.0

528

2750

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

3.8

47.0

145

390

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.0

46.6

221

778

SPAT1254

SPAT

Administration of medicine

2.0

46.1

587

3197

B01AB05

ATC

enoxaparin; parenteral

1.7

46.1

1222

8310

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

7.9

46.0

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

45.9

1351

9438

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.9

45.2

626

3506

V03AG01

ATC

sodium cellulose phosphate; systemic

65.8

45.2

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

5.7

44.8

147

N03AX16

ATC

[U] pregabalin

1.8

44.8

882

5514

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.8

44.8

236

879

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.2

44.7

416

2013

130

Kela drug reimbursment

Malignant tumour

2.2

44.3

409

1974

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.9

43.7

667

3853

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.7

43.4

143

402

WX892

NOMESCO Finland

Monitored bed care

2.5

43.4

303

1296

ZX108

NOMESCO Finland

Inhalation

7.6

43.3

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.4

43.2

334

1495

BAA40

NOMESCO Finland

Unilateral lobectomy of thyroid gland

3.8

43.1

134

362

N20.0

ICD-10 Finland

Calculus of kidney

4.0

43.1

124

317

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

11.7

43.0

XX3DW

NOMESCO Finland

Time consuming IT work

2.1

42.9

485

2527

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

6.0

42.9

129

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.3

42.8

345

1573

ZX114

NOMESCO Finland

Intramuscular

5.5

42.5

151

SPAT1263

SPAT

Sampling

1.6

42.4

1551

11379

T90

ICPC

Diabetes non-insulin dependent

1.7

42.2

902

5759

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

15.8

41.7

A28

ICPC

Limited function/disability NOS

1.8

41.4

684

4047

C10AA05

ATC

atorvastatin; oral

1.6

41.0

1461

10626

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

4.9

40.9

190

BA1AE

NOMESCO Finland

Thyroiid ultrasound examination

4.5

40.7

100

227

UKC02

NOMESCO Finland

Cystoscopy

1.9

40.5

625

3616

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.9

40.5

199

714

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

11.8

40.3

J01DB01

ATC

cefalexin; oral

1.8

40.2

3107

27114

C02AC05

ATC

moxonidine; oral

2.9

40.1

196

701

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.8

40.0

652

3838

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

3.5

39.8

142

421

Z3231

NOMESCO Finland

Registered nurse

1.7

39.6

994

6612

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

3.7

39.5

125

342

C03AA03

ATC

hydrochlorothiazide; oral

2.2

39.5

360

1725

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.6

39.4

247

1004

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

3.5

39.0

136

397

A04

ICPC

Weakness/tiredness general

1.9

39.0

605

3503

D86.0

ICD-10 Finland

Sarcoidosis of lung

5.2

38.7

157

U14

ICPC

Kidney symptom/complaint

4.4

38.6

228

E83.0

ICD-10 Finland

Disorders of copper metabolism

+∞

38.6

N05BA04

ATC

oxazepam; oral

1.7

38.5

979

6528

N06AX11

ATC

mirtazapine; oral

1.6

38.3

1261

8964

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.5

38.1

244

1001

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

4.8

38.1

186

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.9

38.0

522

2905

C08CA13

ATC

lercanidipine; oral

1.9

37.9

573

3288

SPAT1255

SPAT

Intravenous administration of medicine

2.3

37.3

286

1274

E87.2

ICD-10 Finland

Acidosis

370.9

37.1

N05CF01

ATC

zopiclone; oral

1.6

36.7

1188

8394

C10AA01

ATC

simvastatin; oral

1.6

36.6

1360

9920

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

36.3

1183

8368

M05BA04

ATC

alendronic acid; oral

2.1

35.8

383

1951

J01FF01

ATC

clindamycin; systemic

1.6

35.6

1000

6815

KAT00

NOMESCO Finland

Extracorporeal shock wave lithotripsy of pelvis of kidney

5.7

35.6

117

2754A

ICD-9 Finland

Disorders of mineral metabolism, Disorders of calcium metabolism[HYPERCALCAEMIA]

+∞

35.5

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

3.5

35.1

122

356

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.8

34.9

578

3407

KBV00

NOMESCO Finland

Insertion of stent into ureter

7.9

34.5

ZXE10

NOMESCO Finland

More than one and less than three hours

1.6

34.4

1279

9298

D70.82

ICD-10 Finland

Drug-induced neutropenia

4.2

34.4

223

XF600

NOMESCO Finland

Bloodpressure measurement

2.4

34.2

245

1059

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

9.6

34.2

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.0

34.1

423

2270

N18.3

ICD-10 Finland

Chronic kidney disease, stage 3

3.9

33.8

102

270

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

2.3

33.7

264

1186

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

5.4

33.5

124

N20.1

ICD-10 Finland

Calculus of ureter

2.8

33.5

171

626

C07AB02

ATC

metoprolol; systemic

1.7

33.5

698

4394

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

33.4

953

6505

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.9

33.4

446

2454

N20.9

ICD-10 Finland

Urinary calculus, unspecified

3.3

33.3

125

383

A02BC01

ATC

omeprazole; systemic

1.6

33.1

995

6877

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

3.4

32.8

118

352

SPAT1216

SPAT

Assessment of functional ability

1.8

32.7

591

3571

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

6.2

32.7

JN6AD

NOMESCO Finland

CT of torso and neck

3.6

32.6

108

305

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.4

32.6

236

1025

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.9

32.5

160

574

H02AB04

ATC

methylprednisolone; systemic

1.8

32.5

549

3250

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.6

32.5

194

769

B03BA03

ATC

hydroxocobalamin; parenteral

2.4

32.5

235

1020

WW300

NOMESCO Finland

Transfer of autologic stem cells

10.4

32.5

C07AG02

ATC

carvedilol; oral

2.4

32.1

227

975

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

4.2

32.1

209

RD210, ,

NOMESCO Finland

4.2

32.0

205

A10BA02

ATC

metformin; oral

1.6

32.0

975

6751

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

31.8

1562

12004

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

6.7

31.8

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.8

31.8

492

2835

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.6

31.7

197

796

R4110

NOMESCO Finland

Physiotherapy

1.6

31.7

981

6812

S97

ICPC

Chronic ulcer skin

2.3

31.7

258

1178

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

3.3

31.7

119

365

A02BC05

ATC

esomeprazole; systemic

1.5

31.6

1468

11148

ZXE00

NOMESCO Finland

One hour or less

1.5

31.4

1353

10112

WX882

NOMESCO Finland

High dependency care

3.2

31.3

127

408

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

31.3

540

3215

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.7

31.2

710

4566

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.3

31.1

242

1084

X59

ICD-10 Finland

Exposure to unspecified factor

1.7

31.0

707

4549

E66.00

ICD-10 Finland

Metabolic syndrome

2.5

30.9

198

813

212

Kela drug reimbursment

Gout

3.9

30.8

233

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.4

30.7

226

988

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

4.4

30.7

182

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.7

30.7

173

667

E66.01

ICD-10 Finland

Obesity due to excess calories

2.1

30.6

320

1614

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.0

30.5

337

1733

TK820

NOMESCO Finland

Peritoneal dialysis

8.6

30.5

F10.25

ICD-10 Finland

Alcohol dependence continuous use

4.1

30.5

204

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.8

30.5

244

N03AX12

ATC

[U] gabapentin; oral

1.7

30.4

590

3631

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

3.5

30.4

106

310

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

7.7

30.2

SPAT1229

SPAT

Assessment of need for aid

2.1

30.1

303

1505

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.5

30.0

102

293

N16.2*D86.8

ICD-10 Finland

Renal tubulo-interstitial disorders in sarcoidosis

304.8

29.8

ZXA10

NOMESCO Finland

Bilateral

1.7

29.8

672

4306

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

3.9

29.8

234

A10AE05

ATC

insulin detemir; parenteral

2.5

29.8

192

790

M10.3

ICD-10 Finland

Gout due to impairment of renal function

9.5

29.7

C09AA02

ATC

enalapril; systemic

1.7

29.6

676

4346

XX7CT

NOMESCO Finland

Radioiodine therapy of thydoid tissue

5.5

29.6

105

G72.8

ICD-10 Finland

Other specified myopathies

4.2

29.2

189

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

3.4

29.2

108

328

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

29.1

978

6900

K65.0

ICD-10 Finland

Acute peritonitis

4.9

29.0

129

L04AD01

ATC

ciclosporin; systemic

3.7

29.0

257

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.0

29.0

321

1652

B01AC04

ATC

clopidogrel; oral

1.8

28.9

484

2853

UJF30

NOMESCO Finland

Ileoscopy through colon

1.9

28.7

408

2285

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

28.7

558

3434

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.3

28.6

220

980

L03AA02

ATC

filgrastim; parenteral

2.8

28.5

143

519

L04AX01

ATC

azathioprine; systemic

2.5

28.5

178

722

A41.8

ICD-10 Finland

Other specified sepsis

3.7

28.4

256

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.0

28.4

319

1649

P01AB01

ATC

metronidazole; oral, rectal

1.5

28.4

1399

10691

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.6

28.4

780

5248

E05.2

ICD-10 Finland

Thyrotoxicosis with toxic multinodular goitre

4.6

28.2

148

D86.2

ICD-10 Finland

Sarcoidosis of lung with sarcoidosis of lymph nodes

5.3

28.2

106

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

5.5

28.2

E20.0

ICD-10 Finland

Idiopathic hypoparathyroidism

55.4

28.1

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.9

28.1

137

489

J01MA14

ATC

moxifloxacin; systemic

2.0

28.1

346

1848

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

3.8

28.1

226

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

7.3

28.0

BBA50

NOMESCO Finland

Total parathyroidectomy

64.5

27.9

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

27.9

659

4267

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.0

27.8

307

1578

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

27.8

401

2257

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

27.7

1507

11728

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

4.2

27.5

176

KBV10

NOMESCO Finland

Removal of stent from ureter

5.6

27.5

I12.0

ICD-10 Finland

Hypertensive renal disease with renal failure

5.5

27.4

E83.3

ICD-10 Finland

Disorders of phosphorus metabolism and phosphatases

+∞

27.1

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

3.0

27.1

119

401

N06AX16

ATC

venlafaxine; oral

1.8

27.1

488

2936

I50.0

ICD-10 Finland

Congestive heart failure

2.1

27.0

252

1215

A06AH03

ATC

naloxegol; oral

3.8

27.0

214

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

26.9

1554

12211

A46

ICD-10 Finland

Erysipelas

1.7

26.9

540

3348

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

8.1

26.9

A04AA02

ATC

granisetron; systemic, transdermal

2.1

26.9

271

1347

TGC00

NOMESCO Finland

Bronchial lavation

3.0

26.8

120

409

E83.5

ICD-10 Finland

Disorders of calcium metabolism

272.9

26.7

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

3.5

26.7

267

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.1

26.7

278

1398

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.5

26.7

177

738

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

26.6

509

3113

A10BB12

ATC

glimepiride; oral

2.2

26.6

229

1070

A07AA09

ATC

vancomycin; oral

4.1

26.5

177

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.6

26.4

639

4159

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.0

26.4

315

1664

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.8

26.4

462

2756

K70.1

ICD-10 Finland

Alcoholic hepatitis

7.6

26.3

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

2.9

26.2

127

452

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.5

26.1

266

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

26.1

2590

22461

E83.30

ICD-10 Finland

Acid phosphatase deficiency

+∞

26.1

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

4.2

26.0

171

SPAT1234

SPAT

Support of social functional capacity

2.3

25.9

205

924

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.9

25.8

343

1878

ZXE20

NOMESCO Finland

More than three and less than five hours

1.7

25.5

466

2811

N08.2*D89.80

ICD-10 Finland

Immunoglobulin A (IgA) nephropathy

7.3

25.4

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.7

25.3

139

529

E21.5

ICD-10 Finland

Disorder of parathyroid gland, unspecified

25.2

G47.3

ICD-10 Finland

Sleep apnoea

1.6

25.2

798

5530

WX002

NOMESCO Finland

Sedation and analgesia

1.6

25.2

674

4493

WVA20

NOMESCO Finland

Medicine administration

2.9

25.1

120

424

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.7

25.1

531

3335

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

4.0

25.1

180

ZX112

NOMESCO Finland

Subcutaneous

3.2

25.0

100

319

L95

ICPC

Osteoporosis

2.3

24.9

184

806

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

6.0

24.6

NJ3DA

NOMESCO Finland

Long bones of extremities X-ray examination

7.5

24.6

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.0

24.4

264

1346

Z31.5

ICD-10 Finland

Genetic counselling

2.2

24.3

203

936

K92.1

ICD-10 Finland

Melaena

2.2

24.3

203

937

N30.0

ICD-10 Finland

Acute cystitis

1.6

24.2

596

3889

Z2446

NOMESCO Finland

Social worker

2.1

24.1

232

1132

E66.8

ICD-10 Finland

Other obesity

2.3

24.0

186

831

NHQ40

NOMESCO Finland

Amputation of toe

4.2

24.0

155

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

3.1

24.0

101

332

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

24.0

1831

15033

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

87.3

23.7

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.9

23.6

307

1667

E0000UV, ,

ATC

1.4

23.6

1478

11705

E04.9

ICD-10 Finland

Nontoxic goitre, unspecified

3.0

23.6

102

341

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

3.8

23.5

193

SPAT1310

SPAT

Counselling related to known health issue

1.5

23.4

1114

8383

197

Kela drug reimbursment

Sunitinib

7.9

23.4

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

4.8

23.4

109

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

23.4

494

3099

R60.9

ICD-10 Finland

Oedema, unspecified

2.1

23.4

216

1038

N18

ICD-10 Finland

Chronic kidney disease

4.5

23.3

125

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

3.7

23.2

204

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

5.3

23.2

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

22.8

1004

7433

H02AB07

ATC

prednisone; oral

1.7

22.8

480

3006

ED1AA

NOMESCO Finland

Mandibular X-ray examination

5.6

22.7

NF1AA

NOMESCO Finland

Hip X-ray examination

1.8

22.6

361

2091

R79.0

ICD-10 Finland

Abnormal level of blood mineral

26.0

22.6

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.3

22.6

173

770

R60.0

ICD-10 Finland

Localized oedema

1.7

22.6

456

2825

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.1

22.5

230

1149

R31

ICD-10 Finland

Unspecified haematuria

1.8

22.3

355

2054

C01DA14

ATC

isosorbide mononitrate; oral

1.7

22.3

434

2660

WX872

NOMESCO Finland

Intensive care

2.3

22.3

176

793

R13

ICD-10 Finland

Dysphagia

2.0

22.2

270

1433

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.0

22.0

235

1193

JDB10

NOMESCO Finland

Percutaneous gastrostomy

4.0

22.0

157

F10.24

ICD-10 Finland

Alcohol depence active use

3.8

21.8

171

C08CA02

ATC

felodipine; oral

1.8

21.8

330

1881

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.7

21.8

458

2866

KAE12

NOMESCO Finland

Retrograde ureteronephroscopic lithotripsy in pelvis of kidney

5.6

21.8

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.3

21.7

170

763

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

4.4

21.7

124

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

2.8

21.7

106

380

R33

ICD-10 Finland

Retention of urine

1.9

21.6

270

1446

WF004

NOMESCO Finland

Palliative radiotherapy

2.9

21.5

103

365

N06AX21

ATC

duloxetine; oral

1.7

21.5

414

2531

L89

ICD-10 Finland

Decubitus ulcer and pressure area

3.2

21.4

260

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

21.4

681

4706

A12BA01

ATC

potassium chloride; oral

2.4

21.3

151

649

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

21.3

626

4249

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

17.5

21.3

K08.3

ICD-10 Finland

Retained dental root

1.9

21.2

290

1600

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

4.3

21.1

127

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.1

21.0

195

939

A07AA11

ATC

rifaximin; oral

8.1

20.9

E34.9

ICD-10 Finland

Endocrine disorder, unspecified

8.1

20.9

E83.8

ICD-10 Finland

Other disorders of mineral metabolism

+∞

20.8

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.6

20.8

518

3380

AN1

Coronary angiography

1.8

20.8

303

1706

M81.8

ICD-10 Finland

Other osteoporosis

4.1

20.8

137

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.8

20.8

101

361

K76.9

ICD-10 Finland

Liver disease, unspecified

3.6

20.6

192

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.5

20.6

127

512

UJF92

NOMESCO Finland

Capsular endoscopy

3.0

20.6

319

OAB50, ,

SPAT

1.8

20.5

300

1691

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

20.5

346

2036

N03AX14

ATC

levetiracetam; systemic

2.7

20.5

108

403

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

3.0

20.4

299

JN5AQ

NOMESCO Finland

SPECT of thyroid metastasis with low-dose CT

25.6

20.4

Z3226

NOMESCO Finland

Physiotherapist

1.6

20.4

590

3989

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

4.6

20.3

106

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

3.9

20.2

153

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

4.0

20.2

140

R42

ICD-10 Finland

Dizziness and giddiness

1.5

20.1

779

5603

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

4.5

20.1

107

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.0

20.0

292

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

4.0

20.0

141

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

4.0

20.0

141

N05AH04

ATC

quetiapine; oral

1.6

20.0

578

3905

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.5

20.0

125

508

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

4.9

19.9

SPAT1172

SPAT

Guidance concerning hydration

3.0

19.9

304

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

3.6

19.8

183

H3603, E103,

ICD-10 Finland

6.1

19.8

A10BH01

ATC

sitagliptin; oral

1.8

19.8

315

1822

XF402

NOMESCO Finland

ECG with work load test

1.8

19.7

317

1839

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.9

19.7

270

1491

K92.0

ICD-10 Finland

Haematemesis

2.8

19.6

350

A01

ICPC

Pain general/multiple sites

1.7

19.6

359

2163

C73

ICD-10 Finland

Malignant neoplasm of thyroid gland

7.8

19.5

T99

ICPC

Endocr/metab/nutrit disease other

3.3

19.4

215

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

2.9

19.3

309

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.7

19.2

376

2305

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.4

19.2

137

591

M81.0

ICD-10 Finland

Postmenopausal osteoporosis

2.4

19.2

136

585

D86.1

ICD-10 Finland

Sarcoidosis of lymph nodes

5.3

19.2

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

19.2

443

2836

E03.89

ICD-10 Finland

Other specified hypothyroidism

2.3

19.2

148

661

R55

ICD-10 Finland

Syncope and collapse

1.7

19.1

363

2209

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.6

18.9

113

449

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

3.8

18.9

156

KA3EB

NOMESCO Finland

Antegrade pyelography

6.2

18.9

WX725

NOMESCO Finland

Noninvasive ventilation

2.0

18.9

204

1039

L04AA01

ATC

[U] ciclosporin

3.6

18.9

175

M10.0

ICD-10 Finland

Idiopathic gout

2.4

18.8

124

516

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

3.8

18.8

152

R06AE07

ATC

cetirizine; oral

1.4

18.8

1490

12145

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.9

18.7

254

1398

3AC01, ,

NOMESCO Finland

4.4

18.7

109

192

Kela drug reimbursment

Fulvestrant

5.3

18.7

L02BA03

ATC

fulvestrant; parenteral

4.7

18.7

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

18.6

895

6700

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

6.1

18.6

SPAT1301

SPAT

No procedures

1.4

18.6

1065

8226

H02AA02

ATC

fludrocortisone; oral

5.0

18.5

M54.5

ICD-10 Finland

Low back pain

1.4

18.5

1246

9884

JAH00

NOMESCO Finland

Laparotomy

2.6

18.5

110

436

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.0

18.5

200

1020

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.2

18.5

162

763

A02BC03

ATC

lansoprazole; oral

1.4

18.4

963

7317

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.7

18.4

327

1952

B28

ICPC

Limited function/disability (B)

6.4

18.4

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

18.3

643

4526

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

18.3

1329

10671

132

Kela drug reimbursment

Sarcoidosis

5.0

18.3

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.4

18.3

120

499

C08DB01

ATC

diltiazem; oral

2.1

18.3

171

826

N06AB10

ATC

escitalopram; oral

1.5

18.2

636

4470

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.7

18.1

346

2107

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

18.0

1321

10616

E87.8

ICD-10 Finland

Other disorders of electrolyte and fluid balance, not elsewhere classified

52.8

17.9

EP1DS

NOMESCO Finland

PET-MRI of neck metabolism

33.0

17.9

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.3

17.9

132

578

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

3.2

17.9

216

K59.09

ICD-10 Finland

Constipation, unspecified

1.9

17.9

242

1331

9680/3-C77.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph node, NOS

6.7

17.8

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.9

17.8

235

1282

K70.4

ICD-10 Finland

Alcoholic hepatic failure

7.0

17.8

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

3.4

17.8

187

C09CA01

ATC

losartan; oral

1.4

17.8

898

6775

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.2

17.7

146

670

KAC10

NOMESCO Finland

Total nephrectomy with capsule

4.6

17.7

TKC20

NOMESCO Finland

Catheterisation of bladder

1.9

17.7

223

1199

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.5

17.6

679

4867

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

17.6

236

1294

B99

ICD-10 Finland

Other and unspecified infectious diseases

3.0

17.5

255

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.0

17.5

196

1011

XCK10

NOMESCO Finland

Photography of fundus of eye

1.7

17.5

304

1802

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.9

17.4

240

1327

SPAT1211

SPAT

Application of soft bandage

1.7

17.4

307

1828

3012

Kela drug reimbursment

Cabozantinib

7.8

17.4

1502

Kela drug reimbursment

Cabozantinib

7.8

17.4

SPAT1260

SPAT

Consultation of another employee

1.5

17.4

589

4110

WX730

NOMESCO Finland

Conventional respirator

3.5

17.4

175

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.7

17.4

350

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

17.4

637

4519

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

2.9

17.3

284

M13.9

ICD-10 Finland

Arthritis, unspecified

1.8

17.3

262

1493

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.8

17.3

289

1696

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

13.9

17.2

R03AC02

ATC

salbutamol; inhalant

1.3

17.2

1869

15910

N06AB04

ATC

citalopram; systemic

1.5

17.2

671

4818

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

17.2

599

4204

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

2.8

17.1

302

M80.8

ICD-10 Finland

Other osteoporosis with pathological fracture

5.8

17.1

T89

ICPC

Diabetes insulin dependent

2.3

17.1

126

552

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

17.1

642

4575

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.0

17.0

199

1042

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.5

17.0

163

A10AB04

ATC

insulin lispro; parenteral

2.7

17.0

354

JN5JR

NOMESCO Finland

Extensive PET-CT of upper body metabolism (eyebrows to thighs)

7.5

17.0

R5140

NOMESCO Finland

Monitoring the use of the aid

1.6

16.9

371

2341

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

16.9

739

5421

KBE12

NOMESCO Finland

Transluminal endoscopic extraction of calculus of ureter

3.6

16.9

159

A05AA02

ATC

ursodeoxycholic acid; oral

3.1

16.9

234

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

16.9

245

1377

PG5AC

NOMESCO Finland

Contrast examination of injection gate to artery or vein

25.7

16.9

Z71.8

ICD-10 Finland

Other specified counselling

1.4

16.9

1102

8672

394

Kela drug reimbursment

Palbociclib

5.0

16.9

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

2.0

16.9

175

879

B01AF02

ATC

apixaban; oral

1.6

16.9

448

2963

E89.00

ICD-10 Finland

Postirradiation hypothyroidism

14.1

16.8

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.9

16.7

262

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

3.8

16.7

137

R80

ICD-10 Finland

Isolated proteinuria

5.0

16.7

F05.9

ICD-10 Finland

Delirium, unspecified

2.8

16.6

285

1501

Kela drug reimbursment

Palbociclib

4.8

16.6

B81

ICPC

Anaemia vit B12/folate deficiency

2.2

16.5

137

632

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

16.4

982

7609

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.3

16.4

124

549

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.9

16.4

228

1264

105

Kela drug reimbursment

Adrenal cortical hypofunction

20.1

16.4

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

6.1

16.4

N05CD07

ATC

temazepam; oral

1.6

16.3

376

2403

C09AA05

ATC

ramipril; oral

1.4

16.3

771

5737

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

3.8

16.2

126

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

3.3

16.2

183

N02BF02

ATC

pregabalin; oral

1.8

16.2

236

1328

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.9

16.2

256

ZYY98

NOMESCO Finland

Missed treatment contact, no notification given by patient

6.5

16.2

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

3.8

16.2

131

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

3.2

16.1

204

WX2DD

NOMESCO Finland

Low-dose CT of skeleton in whole body

6.8

16.1

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.2

16.1

138

644

K59.1

ICD-10 Finland

Functional diarrhoea

1.9

16.0

199

1064

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

2.2

16.0

138

646

L03AA13

ATC

pegfilgrastim; parenteral

2.0

15.9

172

877

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

15.9

981

7637

Z94.4

ICD-10 Finland

Liver transplant status

6.4

15.8

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

4.2

15.8

102

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.2

15.8

135

630

XPX08

NOMESCO Finland

Intraoperative flow measurement

4.9

15.7

ZXA00

NOMESCO Finland

Right side

1.4

15.6

852

6492

K29.8

ICD-10 Finland

Duodenitis

4.5

15.6

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

12.9

15.6

E20.1

ICD-10 Finland

Pseudohypoparathyroidism

+∞

15.6

GD2SN

NOMESCO Finland

Lung ventilation SPECT

4.6

15.6

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.9

15.6

200

1081

D70.89

ICD-10 Finland

Neutropenic splenomegaly

3.4

15.6

163

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.0

15.5

162

816

A07AA02

ATC

nystatin; oral

1.9

15.5

206

1127

124

Kela drug reimbursment

Inborn metabolic disorders

160.6

15.5

PC5DE

NOMESCO Finland

Ultrasound of kidney circulation with Doppler technic

6.2

15.5

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

3.3

15.4

179

WX704

NOMESCO Finland

Intubation

1.7

15.4

269

1597

B80

ICPC

Iron deficiency anaemia

2.5

15.4

367

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

15.3

324

2025

ZXH04

NOMESCO Finland

Procedure performed in other inpatient unit

5.2

15.3

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.7

15.3

286

1731

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.7

15.3

269

1601

N07BB01

ATC

disulfiram; oral

2.1

15.3

136

645

WX202

NOMESCO Finland

Supraclavicular plexus blockade

3.1

15.3

211

JFB00

NOMESCO Finland

Partial resection of small intestine

3.1

15.3

211

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

3.1

15.2

206

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

5.5

15.2

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.0

15.2

233

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.1

15.2

144

700

J01EA01

ATC

trimethoprim; systemic

1.4

15.2

834

6362

ZYC01

NOMESCO Finland

Remote contact by phone

1.9

15.1

209

1157

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.7

15.1

263

1560

R52.9

ICD-10 Finland

Pain, unspecified

1.6

15.1

342

2176

D64.8

ICD-10 Finland

Other specified anaemias

2.9

15.1

234

C07AA05

ATC

propranolol; systemic

1.4

15.1

638

4645

E89.09

ICD-10 Finland

Postprocedural hypothyroidism, other or several procedures

45.2

15.1

S18

ICPC

Laceration/cut

1.3

15.0

1662

14090

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

4.8

14.9

PB1DE

NOMESCO Finland

Upper extremity arteries ultrasound examination with Doppler method

6.5

14.9

A10AE06

ATC

insulin degludec; parenteral

2.4

14.9

106

458

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

4.1

14.9

C09BA02

ATC

enalapril and diuretics; systemic

1.7

14.9

255

1506

A02BA02

ATC

ranitidine; systemic

1.5

14.8

616

4466

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

3.0

14.8

220

C10AA04

ATC

fluvastatin; oral

1.8

14.8

237

1373

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.6

14.7

327

PBM10

NOMESCO Finland

Closure of arteriovenous fistula of radial artery

16.5

14.7

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

14.7

455

3109

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.5

14.7

381

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

3.0

14.7

216

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.8

14.6

234

1355

Z01.9

ICD-10 Finland

Special examination, unspecified

1.8

14.6

211

1185

GD6AD

NOMESCO Finland

CT of chest and neck

5.1

14.6

M79.6

ICD-10 Finland

Pain in limb

1.3

14.5

1491

12489

M10

ICD-10 Finland

Gout

2.0

14.5

150

753

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.9

14.5

171

899

JN4CD

NOMESCO Finland

Very extensive body CT

2.1

14.5

135

652

XKD00

NOMESCO Finland

Uroflowmetry

1.5

14.5

512

3597

R02

ICPC

Shortness of breath/dyspnoea

1.5

14.5

442

3012

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

2.9

14.4

224

R5110, ,

SPAT

1.7

14.3

294

1823

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

3.1

14.3

188

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

1.9

14.2

179

962

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

4.6

14.2

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

14.2

432

2940

AA1AA

NOMESCO Finland

Head X-ray examination

3.9

14.2

106

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

2.1

14.2

132

637

C10AC01

ATC

colestyramine; oral

2.3

14.2

101

437

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

3.5

14.2

134

A10AB01

ATC

insulin (human); parenteral

2.4

14.1

394

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

5.7

14.1

KBT00

NOMESCO Finland

Extracorporeal shock wave lithotripsy of ureter

6.4

14.1

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

14.1

422

2863

ZXA05

NOMESCO Finland

Left side

1.4

14.1

771

5869

R20.2

ICD-10 Finland

Paraesthesia of skin

1.8

14.0

226

1311

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

4.9

14.0

J02AC01

ATC

fluconazole; systemic

1.3

14.0

1250

10252

A10AD05

ATC

insulin aspart; parenteral

3.1

14.0

185

KBV15

NOMESCO Finland

Cystoscopic change of ureteral stent

4.6

14.0

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.2

14.0

123

581

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.5

14.0

342

ZYC06

NOMESCO Finland

Real-time text-based remote transaction

10.1

13.9

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

3.6

13.9

126

J01CA04

ATC

amoxicillin; systemic

1.3

13.9

2892

26602

R74.0

ICD-10 Finland

Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]

2.7

13.9

290

K91.2

ICD-10 Finland

Postsurgical malabsorption, not elsewhere classified

15.8

13.9

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

2.9

13.9

223

5BA08, ,

NOMESCO Finland

4.9

13.8

WPB10

NOMESCO Finland

Making a convalescent care decision

4.9

13.8

WPA13

NOMESCO Finland

Palliative consultation

4.9

13.8

B01AA03

ATC

warfarin; systemic

1.4

13.8

570

4127

SPAT1097

SPAT

Recording of ECG

1.5

13.7

467

3253

K70.0

ICD-10 Finland

Alcoholic fatty liver

4.1

13.7

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.9

13.7

179

974

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.2

13.7

120

566

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

3.9

13.7

100

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

3.0

13.7

193

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

2.7

13.6

282

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

4.9

13.6

XX2RW, ,

NOMESCO Finland

3.0

13.5

194

SPAT1167

SPAT

Insertion of urinary catheter

2.3

13.5

101

446

TPX15

NOMESCO Finland

Removal of vascular injection port

5.4

13.5

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

5.9

13.5

I81

ICD-10 Finland

Portal vein thrombosis

5.9

13.5

N06AX26

ATC

vortioxetine; oral

1.7

13.5

228

1341

D10

ICPC

Vomiting

1.9

13.5

167

893

C75.0

ICD-10 Finland

Malignant neoplasm: Parathyroid gland

140.5

13.5

JFF13

NOMESCO Finland

Terminal enterostomy

10.1

13.4

R41.0

ICD-10 Finland

Disorientation, unspecified

2.3

13.4

100

441

L17

ICPC

Foot/toe symptom/complaint

1.3

13.4

1019

8158

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.2

13.3

106

481

R79.8

ICD-10 Finland

Other specified abnormal findings of blood chemistry

4.4

13.3

Z3229

NOMESCO Finland

Other healthcare associate professional

1.7

13.3

263

1615

JJA20

NOMESCO Finland

Open biopsy of liver

6.3

13.3

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

3.3

13.3

145

D07AA02

ATC

hydrocortisone; topical

1.5

13.2

433

2991

SPAT1104

SPAT

Monitoring of emergency patient

1.8

13.2

217

1266

K86.1

ICD-10 Finland

Other chronic pancreatitis

3.9

13.2

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.0

13.2

149

772

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.7

13.2

259

1588

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

3.5

13.2

126

SPAT1153

SPAT

Removal of sutures

1.3

13.1

1083

8768

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.7

13.1

228

1353

B07.9

ICD-10 Finland

Verruca simplex

2.1

13.1

125

610

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.8

13.1

186

1040

N02BF01

ATC

gabapentin; oral

1.6

13.1

348

2299

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

5.5

13.0

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

13.0

1477

12485

J01CA08

ATC

pivmecillinam; oral

1.3

12.9

1295

10763

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.7

12.9

235

1411

JCA22

NOMESCO Finland

Endoscopic ligature of oesophageal varices

6.1

12.9

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

12.9

1075

8711

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

5.0

12.9

SPAT1240

SPAT

Therapeutic discussion

1.6

12.9

298

1905

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

4.4

12.9

J01CF05

ATC

flucloxacillin; systemic

1.7

12.8

227

1353

GD1UN

NOMESCO Finland

Lung circulation SPECT

4.9

12.8

PE1YT

NOMESCO Finland

Femoral or popliteal artery PTA with stent

4.1

12.8

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

2.1

12.8

113

535

J01AA02

ATC

doxycycline; systemic

1.3

12.8

2754

25261

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.1

12.7

125

617

SAA04

NOMESCO Finland

Special examination of mouth

1.8

12.7

174

962

N05BA02

ATC

chlordiazepoxide; systemic

2.4

12.7

352

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

12.7

907

7186

R51.80

ICD-10 Finland

Headache

1.5

12.6

474

3365

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

12.6

1199

9890

N11.8

ICD-10 Finland

Other chronic tubulo-interstitial nephritis

15.5

12.6

XG410

NOMESCO Finland

Flow-volume spirometry

2.0

12.5

131

661

ZY010

NOMESCO Finland

Hospital outpatient

1.9

12.5

154

822

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.5

12.5

394

2699

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.9

12.5

164

894

EBA10

NOMESCO Finland

Operative extraction of tooth

1.5

12.5

376

2553

L01CA04

ATC

vinorelbine; systemic

3.4

12.5

126

WX720

NOMESCO Finland

Own respiration

1.9

12.5

156

838

D44.8

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement

24.4

12.4

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.2

12.4

107

502

M81.5

ICD-10 Finland

Idiopathic osteoporosis

3.6

12.4

112

ZX121

NOMESCO Finland

Central venous catheter

5.6

12.4

R63.4

ICD-10 Finland

Abnormal weight loss

2.0

12.4

139

719

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.8

12.4

192

1102

PG1XE

NOMESCO Finland

Other ultrasound examination of blood vessel not elsewhere classified

4.4

12.4

M48.0

ICD-10 Finland

Spinal stenosis

1.5

12.3

403

2782

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

4.6

12.3

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

4.7

12.3

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.6

12.3

261

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

4.1

12.3

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

5.4

12.3

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.1

12.3

110

524

A04.9

ICD-10 Finland

Bacterial intestinal infection, unspecified

4.2

12.2

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

3.7

12.2

104

R10.0

ICD-10 Finland

Acute abdomen

2.1

12.2

109

519

G04CA02

ATC

tamsulosin; oral

1.4

12.2

719

5527

N03AX09

ATC

lamotrigine; oral

2.0

12.1

135

697

Y84

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.5

12.1

114

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.7

12.1

220

1322

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

3.1

12.1

159

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

3.9

12.1

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.3

12.1

417

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.2

12.0

105

495

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.7

12.0

199

1164

R52.2

ICD-10 Finland

Other chronic pain

2.0

12.0

124

623

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.8

12.0

171

957

W19

ICD-10 Finland

Unspecified fall

1.6

12.0

317

2090

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

5.2

12.0

C10AB05

ATC

fenofibrate; oral

2.9

12.0

197

P15

ICPC

Chronic alcohol abuse

2.2

12.0

431

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.1

12.0

118

583

B04

ICPC

Blood symptom/complaint

4.2

12.0

L04AX06

ATC

pomalidomide; oral

10.1

12.0

A29

ICPC

General symptom/complaint other

1.5

11.9

442

3129

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

3.4

11.9

125

J94.8

ICD-10 Finland

Other specified pleural conditions

2.7

11.9

226

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.7

11.9

236

1452

R03BB04

ATC

tiotropium bromide; inhalant

1.6

11.9

312

2055

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.9

11.9

145

773

M84.3

ICD-10 Finland

Stress fracture, not elsewhere classified

2.9

11.9

182

N20.2

ICD-10 Finland

Calculus of kidney with calculus of ureter

4.1

11.8

L01XE04

ATC

[U] sunitinib

11.7

11.8

A12AA12

ATC

[U] calcium acetate

11.7

11.8

D50.8

ICD-10 Finland

Other iron deficiency anaemias

2.9

11.8

188

A10BH02

ATC

vildagliptin; oral

2.7

11.8

244

A79

ICPC

Malignancy NOS

2.6

11.7

256

1507

Kela drug reimbursment

Pomalidomide

10.5

11.7

C09CA03

ATC

valsartan; oral

1.6

11.7

298

1949

C09DA06

ATC

candesartan and diuretics; oral

1.6

11.7

244

1521

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

11.7

1508

12909

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.8

11.6

173

981

N05BA06

ATC

lorazepam; systemic, sublingual

1.8

11.6

167

937

N05BA01

ATC

diazepam; systemic, rectal

1.5

11.6

397

2765

WZA10

NOMESCO Finland

Extensive medical or dental certificate

2.9

11.6

179

F50.9

ICD-10 Finland

Eating disorder, unspecified

4.1

11.6

WX199

NOMESCO Finland

Other local analgesia

2.0

11.6

117

584

2522

FHL

Removal of parathyroidism or multiple parathyroidism (including removal of adenoma or total removal)

22.9

11.6

K83.1

ICD-10 Finland

Obstruction of bile duct

2.7

11.5

218

G72.9

ICD-10 Finland

Myopathy, unspecified

3.7

11.5

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.6

11.5

285

1850

A03

ICPC

Fever

1.4

11.5

515

3774

I95.9

ICD-10 Finland

Hypotension, unspecified

2.9

11.5

185

C10AX09

ATC

ezetimibe; oral

1.5

11.5

448

3203

2754B

ICD-9 Finland

Disorders of mineral metabolism, Disorders of calcium metabolism[HYPERCALCURIA]

+∞

11.5

WX204

NOMESCO Finland

Axillary plexus blockaced

2.0

11.4

121

614

E31.00

ICD-10 Finland

APECED syndrome

120.4

11.4

E87.3

ICD-10 Finland

Alkalosis

120.4

11.4

I50

ICD-10 Finland

Heart failure

2.2

11.4

414

J01DA01

ATC

[U] cefalexin

1.3

11.4

2049

18230

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

2.8

11.4

203

ZX095

NOMESCO Finland

Combined chemoradiotherapy

3.9

11.4

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.3

11.3

396

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

2.7

11.3

226

C08CA05

ATC

nifedipine; systemic

1.8

11.3

183

1064

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

15.1

11.3

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

3.8

11.3

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.9

11.3

132

694

SPAT1312

SPAT

General health counselling

1.3

11.3

1024

8371

393

Kela drug reimbursment

Pomalidomide

8.9

11.2

K65.9

ICD-10 Finland

Peritonitis, unspecified

9.6

11.2

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

9.6

11.2

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.1

11.2

106

516

H3600, E113,

ICD-10 Finland

3.3

11.2

125

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.9

11.2

143

774

PE1BT

NOMESCO Finland

Femoral artery extensive PTA

4.5

11.2

E46

ICD-10 Finland

Unspecified protein-energy malnutrition

17.1

11.2

WVA30

NOMESCO Finland

Intramuscular and subcutaneous injection

4.6

11.2

TGD00

NOMESCO Finland

Needle biopsy of lung

4.6

11.2

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

3.1

11.1

151

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.2

11.1

451

H05BX02

ATC

paricalcitol; systemic

25.1

11.1

2520A

ICD-9 Finland

Disorders of parathyroid gland, Hyperparathyroidism

25.1

11.1

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.9

11.1

140

755

A10AA01, ,

ATC

2.6

11.1

252

B37.08

ICD-10 Finland

Other candidal stomatitis

3.3

11.1

121

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

5.3

11.1

UKA02

NOMESCO Finland

Retrograde ureteronephroscopy

5.3

11.1

N06AB06

ATC

sertraline; oral

1.5

11.0

341

2327

K72.9

ICD-10 Finland

Hepatic failure, unspecified

4.3

11.0

EE1AA

NOMESCO Finland

X-ray of upper jaw or palate

5.7

11.0

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

5.7

11.0

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.7

11.0

221

1365

G41.9

ICD-10 Finland

Status epilepticus, unspecified

4.8

10.9

UKB02

NOMESCO Finland

Retrograde ureteroscopy

3.4

10.9

117

BB1AN

NOMESCO Finland

Parathyroid gland isotope imaging, 1 isotope

43.4

10.9

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.1

10.9

475

160

Kela drug reimbursment

exenatide

2.6

10.9

225

Z71.9

ICD-10 Finland

Counselling, unspecified

1.6

10.9

242

1533

N30.9

ICD-10 Finland

Cystitis, unspecified

1.7

10.8

206

1253

C10AA03

ATC

pravastatin; oral

1.7

10.8

192

1146

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

10.8

498

3668

UJD02

NOMESCO Finland

Gastroscopy

1.9

10.8

144

791

Z50.1

ICD-10 Finland

Other physical therapy

1.8

10.8

167

960

M80.5

ICD-10 Finland

Idiopathic osteoporosis with pathological fracture

4.3

10.8

E27.1

ICD-10 Finland

Primary adrenocortical insufficiency

10.6

10.8

B74

ICPC

Malignant neoplasm blood other

8.8

10.7

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

3.6

10.7

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.2

10.7

432

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

2.9

10.7

171

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.6

10.7

248

1587

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

2.6

10.7

245

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.7

10.7

196

1182

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

2.5

10.7

251

E20

ICD-10 Finland

Hypoparathyroidism

60.2

10.6

T29

ICPC

Endocr/metab/nutr sympt/compl other

2.4

10.6

294

WX722

NOMESCO Finland

PEEP

1.8

10.6

145

803

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

3.1

10.6

135

C09CA06

ATC

candesartan; oral

1.3

10.5

769

6089

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

4.2

10.5

YNB10

NOMESCO Finland

Collection of stem cells for transplant

11.2

10.5

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

3.2

10.5

125

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.6

10.5

229

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.1

10.5

455

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.1

10.5

102

502

207

Kela drug reimbursment

Chronic arrhythmias

1.4

10.5

486

3581

NF3AA

NOMESCO Finland

Femur X-ray examination

2.3

10.5

364

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.6

10.5

241

SPAT1325

SPAT

Vaccination

1.3

10.5

1078

8939

NGQ20

NOMESCO Finland

Amputation of lower leg

4.8

10.5

FM1LE

NOMESCO Finland

Combined ultrasound and EKG examination of heart with tolerance test

4.8

10.5

E04.0

ICD-10 Finland

Nontoxic diffuse goitre

3.6

10.5

KH1AA

NOMESCO Finland

Urinary tract X-ray examination without contrast

2.8

10.4

190

E85.9

ICD-10 Finland

Amyloidosis, unspecified

110.3

10.4

B05XA09

ATC

sodium phosphate; parenteral

+∞

10.4

2753A

ICD-9 Finland

Disorders of mineral metabolism, Disorders of phosphorus metabolism[HYPOPHOSPHATHAEMIA FAMILIARIS]

+∞

10.4

N16.3

ICD-10 Finland

Renal tubulo-interstitial disorders in metabolic diseases

+∞

10.4

N05AN01

ATC

lithium; oral

2.3

10.4

321

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.3

10.4

1824

16108

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

3.2

10.4

131

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

3.7

10.4

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.3

10.4

328

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

2.2

10.4

418

168

Kela drug reimbursment

Axitinib

32.6

10.3

S76

ICPC

Skin infection other

1.7

10.3

176

1040

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

3.5

10.3

K06.18

ICD-10 Finland

Another gingival hyperplasia

5.1

10.3

R07.3

ICD-10 Finland

Other chest pain

1.5

10.3

315

2145

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.0

10.3

110

561

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.0

10.3

112

575

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.9

10.3

128

688

TPH04, ,

SPAT

3.0

10.2

148

M17.4

ICD-10 Finland

Other secondary gonarthrosis, bilateral

4.6

10.2

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.9

10.2

129

696

I25.2

ICD-10 Finland

Old myocardial infarction

1.8

10.2

151

856

JAH01

NOMESCO Finland

Laparoscopy

1.9

10.2

130

704

C03BA11

ATC

indapamide; oral

2.2

10.2

408

C02EA02, ,

ATC

1.9

10.1

124

662

K59.0

ICD-10 Finland

Constipation

1.7

10.1

176

1045

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

3.4

10.1

103

EBA00

NOMESCO Finland

Extraction of tooth

1.3

10.1

1176

9893

H04AA01

ATC

glucagon; nasal, parenteral

2.6

10.1

222

M25.5

ICD-10 Finland

Pain in joint

1.3

10.1

1066

8863

SPAT1252

SPAT

Overall medication plan or its review

1.6

10.1

208

1293

A10BK01

ATC

dapagliflozin; oral

1.6

10.1

230

1466

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.6

10.1

232

1482

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

4.3

10.0

TJA33

NOMESCO Finland

Percutaneous introduction of peritoneal dialysis catheter

8.4

10.0

N11.9

ICD-10 Finland

Chronic tubulo-interstitial nephritis, unspecified

8.4

10.0

K55.0

ICD-10 Finland

Acute vascular disorders of intestine

3.8

10.0

Z73.6

ICD-10 Finland

Limitation of activities due to disability

3.8

10.0

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

1.6

10.0

233

1492

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

10.0

505

3775

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

4.8

10.0

UJC01

NOMESCO Finland

Scopy of lower throat

3.2

10.0

124

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

4.6

10.0

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

4.6

10.0

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

2.5

9.9

236

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

3.0

9.9

146

M79.7

ICD-10 Finland

Fibromyalgia

2.0

9.8

107

549

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.4

9.8

422

3067

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.7

9.8

164

963

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2.5

9.8

237

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.7

9.8

159

926

ZX070

NOMESCO Finland

Intensity modified radiotherapy

2.4

9.8

286

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.5

9.8

264

1749

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.7

9.8

167

987

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.5

9.8

285

1920

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

4.4

9.8

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.0

9.8

475

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.1

9.8

428

N05CF02

ATC

zolpidem; oral

1.4

9.8

529

4000

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

4.5

9.8

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

3.5

9.8

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.5

9.7

317

2186

XF404

NOMESCO Finland

Ambulatory ECG

1.6

9.7

245

1598

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

2.8

9.7

169

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

2.8

9.7

169

J01FA06

ATC

roxithromycin; oral

1.3

9.7

1271

10830

A10AB06

ATC

insulin glulisine; parenteral

3.5

9.7

SPAT1125

SPAT

Stoma care and guidance

2.6

9.7

215

A10AD01

ATC

insulin (human); parenteral

2.7

9.7

192

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.5

9.7

271

1811

E87.7

ICD-10 Finland

Fluid overload

55.1

9.6

E21.4

ICD-10 Finland

Other specified disorders of parathyroid gland

55.1

9.6

8260/3-C64.9

ICD-O-3

Papillary adenocarcinoma, NOS, of kidney, NOS

5.3

9.6

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.8

9.6

133

739

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.8

9.6

144

820

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.0

9.6

101

513

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

3.9

9.6

D72.8

ICD-10 Finland

Other specified disorders of white blood cells

3.4

9.6

102

K85.2

ICD-10 Finland

Alcohol-induced acute pancreatitis

4.4

9.5

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

9.5

249

1638

Z93.2

ICD-10 Finland

Ileostomy status

4.8

9.5

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

2.6

9.5

217

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

4.6

9.5

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

1.7

9.5

186

1141

Z02.7

ICD-10 Finland

Issue of medical certificate

1.6

9.5

225

1447

PB1AC

NOMESCO Finland

Angiography of upper extremity with X-ray

15.0

9.5

K90.3

ICD-10 Finland

Pancreatic steatorrhoea

4.0

9.5

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.0

9.5

460

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

3.1

9.5

123

L29.9

ICD-10 Finland

Pruritus, unspecified

2.1

9.4

441

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.8

9.4

146

840

BBA99

NOMESCO Finland

Other operations on parathyroid gland

100.3

9.4

E55.0

ICD-10 Finland

Rickets, active

100.3

9.4

WVA20, ,

SPAT

1.9

9.4

117

629

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.2

9.4

349

M14.5

ICD-10 Finland

Arthropathies in other endocrine, nutritional and metabolic disorders

+∞

9.4

2750A

ICD-9 Finland

Disorders of mineral metabolism, Disorders of iron metabolism[HAEMOCHROMATOSIS]

+∞

9.4

PG5ST

NOMESCO Finland

Endovascular thrombolysis of arterio-venous shunt for dialysis with radiological guidance

+∞

9.4

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.5

9.4

332

2329

PB1BC

NOMESCO Finland

Extensive angiography of upper extremity with X-ray

12.4

9.3

R04.0

ICD-10 Finland

Epistaxis

1.6

9.3

236

1541

N06AA09

ATC

amitriptyline; systemic

1.5

9.3

290

1982

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.8

9.3

129

718

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

2.9

9.3

146

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.8

9.3

157

U04

ICPC

Incontinence urine

1.6

9.3

187

1157

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.7

9.2

165

988

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.4

9.2

417

3058

TAB00

NOMESCO Finland

Lumbar puncture

1.8

9.2

136

772

SPAT1279

SPAT

Preparation of immediate hospitalisation

3.2

9.2

115

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.5

9.2

307

2129

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

1.8

9.1

122

671

H25.8

ICD-10 Finland

Other senile cataract

1.4

9.1

364

2611

S06.0

ICD-10 Finland

Concussion

1.5

9.1

319

2232

D86

ICD-10 Finland

Sarcoidosis

7.7

9.1

M87.1

ICD-10 Finland

Osteonecrosis due to drugs

4.3

9.1

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.7

9.1

149

871

H3600, E103,

ICD-10 Finland

3.6

9.1

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

1.7

9.1

160

955

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

4.6

9.1

ZY000

NOMESCO Finland

Hospital inpatient

2.9

9.0

148

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

2.2

9.0

335

M01AB01

ATC

indometacin; systemic, rectal

1.6

9.0

219

1418

NFQ20

NOMESCO Finland

Amputation of femur

3.7

9.0

C09CA07

ATC

telmisartan; oral

1.6

9.0

226

1475

K83.0

ICD-10 Finland

Cholangitis

2.5

9.0

206

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.5

8.9

218

UDC00

NOMESCO Finland

Ear microscopy

1.6

8.9

232

1525

SBB10

NOMESCO Finland

Dental impressions

1.6

8.9

198

1256

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

3.7

8.9

K12.10

ICD-10 Finland

Stomatitis NOS

3.7

8.9

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

3.0

8.9

128

D01

ICPC

Abdominal pain/cramps general

1.4

8.9

366

2642

PJA10

NOMESCO Finland

Exploration of lymph nodes

2.7

8.9

178

Z01.2

ICD-10 Finland

Dental examination

1.2

8.9

1510

13217

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.5

8.8

249

1666

WVA30, ,

SPAT

1.6

8.8

217

1408

GBB00

NOMESCO Finland

Tracheostomy

2.8

8.8

150

N06AX12

ATC

bupropion; oral

1.6

8.8

189

1188

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

2.1

8.8

392

RS221, ,

NOMESCO Finland

2.7

8.8

173

NFC20

NOMESCO Finland

Secondary implantation of hip prosthesis

2.3

8.8

269

N25.0

ICD-10 Finland

Renal osteodystrophy

10.7

8.8

F32

ICD-10 Finland

Depressive episode

1.7

8.8

143

836

A10BK03

ATC

empagliflozin; oral

1.5

8.7

296

2058

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

2.4

8.7

239

K56.7

ICD-10 Finland

Ileus, unspecified

2.4

8.7

239

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

8.7

650

5152

K20

ICD-10 Finland

Oesophagitis

2.3

8.7

264

G44.2

ICD-10 Finland

Tension-type headache

1.4

8.7

391

2866

N06AB03

ATC

fluoxetine; oral

1.4

8.7

354

2550

Z00.0

ICD-10 Finland

General medical examination

1.3

8.7

601

4714

H06.2*E05.9

ICD-10 Finland

Dysthyroid exophthalmos

4.2

8.6

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

3.1

8.6

109

D63.8

ICD-10 Finland

Anaemia in other chronic diseases classified elsewhere

7.6

8.6

J01XX08

ATC

linezolid; systemic

3.4

8.6

F05.8

ICD-10 Finland

Other delirium

3.3

8.6

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

2.1

8.6

409

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

2.9

8.6

136

ZX120, ,

SPAT

2.6

8.6

187

N04BC05

ATC

pramipexole; oral

1.5

8.5

239

1597

WF099

NOMESCO Finland

Other radiotherapy

3.6

8.5

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.8

8.5

128

730

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.2

8.5

337

D12

ICPC

Constipation

1.8

8.5

117

650

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.1

8.5

397

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.7

8.5

165

1011

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.7

8.5

139

813

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

2.6

8.5

182

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

8.5

494

N26

ICD-10 Finland

Unspecified contracted kidney

20.1

8.5

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

8.4

921

7661

J86.9

ICD-10 Finland

Pyothorax without fistula

3.0

8.4

116

BB1AQ

NOMESCO Finland

Parathyroidgland SPECT with low dose CT

90.3

8.4

E89.1

ICD-10 Finland

Postprocedural hypoinsulinaemia

90.3

8.4

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.1

8.4

372

K02.1

ICD-10 Finland

Caries of dentine

1.2

8.4

1917

17257

TJD20

NOMESCO Finland

Change of gastrostomy tube

4.3

8.4

N39.1

ICD-10 Finland

Persistent proteinuria, unspecified

4.3

8.4

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.4

8.4

410

3047

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

1.8

8.4

112

617

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.1

8.4

346

M05BA07

ATC

risedronic acid; oral

1.9

8.4

510

158

Kela drug reimbursment

Everolimus

12.8

8.4

C25.4

ICD-10 Finland

Malignant neoplasm: Endocrine pancreas

12.8

8.4

K07

ICPC

Swollen ankles/oedema

1.7

8.3

147

878

K70.9

ICD-10 Finland

Alcoholic liver disease, unspecified

6.7

8.3

I95.1

ICD-10 Finland

Orthostatic hypotension

1.9

8.3

108

589

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

2.4

8.3

244

8010/3-C75.0

ICD-O-3

Carcinoma, NOS, of parathyroid gland

+∞

8.3

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

1.9

8.3

504

C08CA10

ATC

nilvadipine; oral

2.3

8.3

257

M86.1

ICD-10 Finland

Other acute osteomyelitis

8.5

8.3

L60.0

ICD-10 Finland

Ingrowing nail

1.7

8.3

144

857

M87.9

ICD-10 Finland

Osteonecrosis, unspecified

3.6

8.3

Z29.9

ICD-10 Finland

Prophylactic measure, unspecified

3.1

8.3

112

JCA55

NOMESCO Finland

Endoscopic dilatation of oesophagus

3.1

8.3

112

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.7

8.2

138

813

I20.00

ICD-10 Finland

Unstable angina

2.2

8.2

309

L01EX07

ATC

cabozantinib; oral

7.1

8.2

C07AB03

ATC

atenolol; systemic

1.6

8.2

164

1012

D44.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Adrenal gland

2.8

8.2

145

WX290

NOMESCO Finland

Other blockage of nerve

1.2

8.2

1467

12874

WX212

NOMESCO Finland

Femoral plexus blockade

2.0

8.2

396

E05.80

ICD-10 Finland

Subacute thyrotoxicosis

3.2

8.2

BB1BN

NOMESCO Finland

Parathyroid gland isotope imaging, 2 isotopes

14.5

8.2

V03AE04

ATC

calcium acetate and magnesium carbonate; systemic

14.5

8.2

BA1NN

NOMESCO Finland

I-131 dose capsel measurement

14.5

8.2

TQW40

NOMESCO Finland

Remowal of suture of skin

1.5

8.2

219

1450

I50.1

ICD-10 Finland

Left ventricular failure

1.7

8.1

129

748

L40.0

ICD-10 Finland

Psoriasis vulgaris

1.7

8.1

129

748

A06AC51

ATC

ispaghula, combinations; oral

1.7

8.1

144

862

P01BA02

ATC

hydroxychloroquine; oral

1.5

8.1

255

1747

288

Kela drug reimbursment

Febuxostat

4.8

8.1

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.4

8.1

416

3116

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

8.1

721

5845

25200

ICD-8 Finland

Diseases of parathyroid gland, Hyperparathyroidism

33.4

8.1

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

3.0

8.1

119

ZX100, ,

SPAT

17.2

8.1

Y88

ICD-10 Finland

Sequelae with surgical and medical care as external cause

3.4

8.1

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

1.9

8.1

510

SPAT1238

SPAT

Brief therapy

2.5

8.0

199

A10BX07

ATC

[U] liraglutide

2.9

8.0

130

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.3

8.0

728

5914

E03

ICD-10 Finland

Other hypothyroidism

1.6

8.0

179

1136

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.3

8.0

242

J01MA06

ATC

norfloxacin; oral

1.4

8.0

390

2895

B01AB04

ATC

dalteparin; parenteral

1.7

8.0

153

934

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

3.6

8.0

H36.00

ICD-10 Finland

Diabetic background retinopathy

2.8

8.0

136

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

2.2

8.0

287

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

1.8

8.0

105

576

177

Kela drug reimbursment

Insulin glargine 300 U / ml

2.4

8.0

212

N28.1

ICD-10 Finland

Cyst of kidney

2.4

8.0

206

D89.80

ICD-10 Finland

Immunoglobulin A (IgA) deposits in organisms

7.2

7.9

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

4.3

7.9

L01EF01

ATC

palbociclib; oral

4.3

7.9

I48.2

ICD-10 Finland

Chronic atrial fibrillation

1.7

7.9

136

807

WF002

NOMESCO Finland

Radical radiotherapy

1.6

7.9

179

1141

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

3.0

7.9

110

E66.0

ICD-10 Finland

Obesity due to excess calories

3.0

7.9

110

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

1.7

7.9

125

726

F34.1

ICD-10 Finland

Dysthymia

1.9

7.9

100

543

D11

ICPC

Diarrhoea

1.4

7.8

339

2467

S01.0

ICD-10 Finland

Open wound of scalp

1.5

7.8

240

1636

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

6.1

7.8

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

3.1

7.8

100

B82

ICPC

Anaemia other/unspecified

2.0

7.8

445

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

2.8

7.8

138

N39.9

ICD-10 Finland

Disorder of urinary system, unspecified

2.3

7.8

233

PA6AE

NOMESCO Finland

Ulrasound examination of neck vasculature

3.2

7.8

7151

FHL

Kidney transplantation

10.8

7.8

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.0

7.8

404

ZX080

NOMESCO Finland

Image guided radiotherapy

2.0

7.8

370

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.3

7.7

848

7047

XQ800

NOMESCO Finland

Prick test

1.5

7.7

202

1331

A10BJ02

ATC

liraglutide; parenteral

2.0

7.7

378

XG466

NOMESCO Finland

Sleep oxymetry

1.9

7.7

468

4019X

ICD-9 Finland

Essential hypertension, Unspecified

2.1

7.7

351

R00.2

ICD-10 Finland

Palpitations

1.5

7.7

232

1576

SXC03

NOMESCO Finland

Other oral or dental procedure

2.8

7.7

139

R18

ICD-10 Finland

Ascites

2.2

7.7

305

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.2

7.7

292

NF1DA

NOMESCO Finland

X-ray of hips

2.0

7.7

379

K29.2

ICD-10 Finland

Alcoholic gastritis

7.4

7.7

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

2.4

7.6

198

L29.8

ICD-10 Finland

Other pruritus

2.5

7.6

192

E000003, ,

ATC

1.7

7.6

122

710

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.7

7.6

125

733

TQW99

NOMESCO Finland

Other minor procedure on skin

1.6

7.6

154

955

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.1

7.6

313

Z2221

NOMESCO Finland

Medical doctor

1.3

7.6

788

6506

A10BX02

ATC

repaglinide; oral

2.7

7.6

146

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.2

7.6

268

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

8.9

7.5

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.1

7.5

301

I20.09

ICD-10 Finland

Unstable angina

1.7

7.5

134

804

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

7.5

1150

9911

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.2

7.5

1067

9124

WX610

NOMESCO Finland

Patient controlled analgesia

3.3

7.5

D07AB08

ATC

desonide; topical

1.4

7.5

319

2315

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

2.0

7.5

417

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

1.9

7.4

524

SBA00

NOMESCO Finland

Microbiological examinations

2.0

7.4

411

E03.80

ICD-10 Finland

Hypothyroidism caused by autoimmune thyroiditis

2.2

7.4

283

I82.88

ICD-10 Finland

Embolism and thrombosis of other specified veins

2.2

7.4

283

2521A

ICD-9 Finland

Disorders of parathyroid gland, Hypoparathyroidism

80.3

7.4

C02CA01

ATC

prazosin; oral

2.4

7.4

195

WPA45

NOMESCO Finland

Continuous drug infusion in palliative care

6.5

7.4

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.3

7.4

447

3435

4CJ01, ,

NOMESCO Finland

13.4

7.4

NK6AN

NOMESCO Finland

Total body bone isotope imaging

1.9

7.4

504

K85.8

ICD-10 Finland

Other acute pancreatitis

3.3

7.4

RS220, ,

NOMESCO Finland

2.6

7.4

154

A07EA06

ATC

budesonide; oral, local oral

1.8

7.4

109

621

QDB99

NOMESCO Finland

Other procedure for wound of skin of lower limb

4.0

7.3

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

2.9

7.3

115

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.7

7.3

127

757

27340

ICD-8 Finland

Other and unspecified congenital disorders of metabolism, Other disorders involving metabolism of minerals

+∞

7.3

E85.3

ICD-10 Finland

Secondary systemic amyloidosis

+∞

7.3

2581B

ICD-9 Finland

Polyglandular dysfunction and related disorders, Other combinations of endocrine dysfunction[AUTOIMMUNE-POLYENDOCRINOPATHY-CANDIDOSIS-ECTOD DYST]

+∞

7.3

N07BA03

ATC

varenicline; oral

1.7

7.3

131

788

E000001, ,

ATC

1.3

7.3

577

4603

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.4

7.3

306

2216

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

6.8

7.3

N18

ICPC

Paralysis/weakness

2.2

7.3

279

L02BG06

ATC

exemestane; oral

2.2

7.3

279

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.2

7.3

279

M14.6*E11.6

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic neuropathic

9.4

7.3

M03BX02

ATC

tizanidine; oral

1.2

7.3

2025

18474

M54.4

ICD-10 Finland

Lumbago with sciatica

1.3

7.3

547

4335

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

2.4

7.2

185

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

1.9

7.2

500

JJC00

NOMESCO Finland

Allogenic transplantation of liver

6.2

7.2

3XA02, ,

NOMESCO Finland

15.8

7.2

YNB00

NOMESCO Finland

Excision of bone marrow for transplantation

15.8

7.2

K55.8

ICD-10 Finland

Other vascular disorders of intestine

4.3

7.2

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.5

7.2

204

1369

J01MA01

ATC

ofloxacin; systemic

1.5

7.2

239

1658

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

2.2

7.2

242

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.7

7.2

119

701

E05

ICD-10 Finland

Thyrotoxicosis [hyperthyroidism]

2.9

7.2

111

N21.0

ICD-10 Finland

Calculus in bladder

2.8

7.2

122

M81.4

ICD-10 Finland

Drug-induced osteoporosis

3.9

7.2

WX213

NOMESCO Finland

Lower leg blockade

3.1

7.2

M821, E2109,

ICD-10 Finland

30.1

7.1

D83.1

ICD-10 Finland

Common variable immunodeficiency with predominant immunoregulatory T-cell disorders

30.1

7.1

4039A

ICD-9 Finland

Hypertensive renal disease, Unspecified

30.1

7.1

KAS40

NOMESCO Finland

Excision of transplanted kidney

20.0

7.1

L94.2

ICD-10 Finland

Calcinosis cutis

20.0

7.1

M47.82

ICD-10 Finland

Other spondylosis, cervical region

1.7

7.1

127

763

A10BX04

ATC

[U] exenatide

2.9

7.1

106

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

1.8

7.1

532

101

Kela drug reimbursment

Anterior pituitary hypofunction

3.4

7.1

JFH10

NOMESCO Finland

Total colectomy and ileostomy

6.6

7.1

XF612

NOMESCO Finland

Measurement of central venous pressure

7.9

7.1

Z83.4

ICD-10 Finland

Family history of other endocrine, nutritional and metabolic diseases

7.9

7.1

E44.0

ICD-10 Finland

Moderate protein-energy malnutrition

7.9

7.1

L02

ICPC

Back symptom/complaint

1.4

7.1

294

2125

K73.80

ICD-10 Finland

Non-alcoholic fatty liver (NASH, Non Alcoholic Steatohepatitis)

4.1

7.1

L14

ICPC

Leg/thigh symptom/complaint

1.5

7.1

253

1780

N28.9

ICD-10 Finland

Disorder of kidney and ureter, unspecified

4.2

7.0

D62

ICD-10 Finland

Acute posthaemorrhagic anaemia

3.1

7.0

S72.2

ICD-10 Finland

Subtrochanteric fracture

3.1

7.0

198

Kela drug reimbursment

Sorafenib

7.0

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

2.7

7.0

135

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.3

7.0

525

4159

NH1AD

NOMESCO Finland

Ankle and foot CT

2.0

7.0

358

TQW80

NOMESCO Finland

Local dermatologic skincare

1.9

7.0

449

A10BJ06

ATC

semaglutide; parenteral

1.6

7.0

138

852

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

2.3

7.0

207

E53.8

ICD-10 Finland

Deficiency of other specified B group vitamins

3.4

7.0

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

2.6

7.0

141

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

3.3

7.0

JFG40

NOMESCO Finland

Revision of enterostomy or colostomy without laparotomy

4.4

7.0

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.1

7.0

311

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

2.2

6.9

265

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

3.7

6.9

L03

ICPC

Low back symptom/complaint

1.2

6.9

912

7728

A02BC04

ATC

rabeprazole; oral

1.4

6.9

256

1813

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.6

6.9

146

917

WX320

NOMESCO Finland

Spinalanesthesy

1.3

6.9

772

6424

C22.1

ICD-10 Finland

Malignant neoplasm: Intrahepatic bile duct carcinoma

4.0

6.9

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.2

6.9

240

D07AC01

ATC

betamethasone; topical

1.2

6.9

1169

10167

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

2.5

6.8

154

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

3.2

6.8

JN1AD

NOMESCO Finland

CT examination of upper part of abdomen

3.4

6.8

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.5

6.8

194

1303

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prosthodontic work

1.7

6.8

126

764

R06.5

ICD-10 Finland

Mouth breathing

1.4

6.8

256

1817

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

6.8

785

6551

K25.7

ICD-10 Finland

Gastric ulcer, Chronic without haemorrhage or perforation

2.7

6.8

131

NG1DA

NOMESCO Finland

X-ray of knees

2.1

6.8

300

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.8

6.8

554

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

2.2

6.8

241

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

2.2

6.8

267

Q61.2

ICD-10 Finland

Polycystic kidney, autosomal dominant

3.8

6.8

-54

ICPC

Repair/fix-suture/cast/prosth device

2.0

6.8

341

P16

ICPC

Acute alcohol abuse

2.4

6.8

197

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

10.9

6.8

M05BX06

ATC

romosozumab; parenteral

10.9

6.8

PBU84

NOMESCO Finland

Plastic repair of arteriovenous fistula from artery of upper extremity

9.3

6.8

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.6

6.8

132

812

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.4

6.8

290

2108

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.0

6.8

383

KCE02

NOMESCO Finland

Transluminal endoscopic extraction of calculus from bladder

3.0

6.8

C10AA02

ATC

lovastatin; oral

1.8

6.8

497

322

Kela drug reimbursment

Sunitinib

6.1

6.8

G63.8*N18.8

ICD-10 Finland

Uraemic neuropathy

40.1

6.8

H04.10

ICD-10 Finland

Dry eye syndrome

1.4

6.8

360

2713

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.5

6.7

202

1372

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.2

6.7

255

K86.3

ICD-10 Finland

Pseudocyst of pancreas

4.3

6.7

M84.4

ICD-10 Finland

Pathological fracture, not elsewhere classified

4.3

6.7

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

2.2

6.7

236

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.4

6.7

335

2498

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.7

6.7

110

646

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

1.8

6.7

491

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

1.8

6.7

101

579

L01XE33

ATC

[U] palbociclib

3.9

6.7

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

1.6

6.7

130

799

G62.8

ICD-10 Finland

Other specified polyneuropathies

2.7

6.7

121

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

2.3

6.7

211

UJF02

NOMESCO Finland

Peroral enteroscopy

3.4

6.7

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.9

6.7

T92

ICPC

Gout

2.0

6.7

316

R4130

NOMESCO Finland

Speech therapy

1.9

6.7

385

361

Kela drug reimbursment

Axitinib

22.5

6.7

WE300

NOMESCO Finland

Profylactive therapy of malignancy with biomoidiers

22.5

6.7

ECB20

NOMESCO Finland

Oral alveoplasty

2.5

6.7

156

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

2.1

6.6

283

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

6.6

2408

22414

K85

ICD-10 Finland

Acute pancreatitis

2.3

6.6

218

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

2.3

6.6

193

C07AB05

ATC

betaxolol; oral

2.0

6.6

358

P03

ICPC

Feeling depressed

1.4

6.6

256

1827

K02.9

ICD-10 Finland

Dental caries, unspecified

2.2

6.6

231

6BA02, ,

NOMESCO Finland

6.4

6.6

A10AA02, ,

ATC

2.0

6.6

372

PG1UT

NOMESCO Finland

Percutaneous aspiration throbectomy

4.0

6.6

U02

ICPC

Urinary frequency/urgency

1.3

6.6

447

3489

R4120

NOMESCO Finland

Occupational therapy

1.5

6.6

173

1142

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

1.8

6.6

552

C73.90

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland) without histology

5.9

6.6

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

2.3

6.6

206

K31.7

ICD-10 Finland

Polyp of stomach and duodenum

3.6

6.6

JA3FT

NOMESCO Finland

Exchange abdominal catheter with radiological guidance

12.3

6.6

C03DB01

ATC

amiloride; oral

12.3

6.6

A49.8

ICD-10 Finland

Other bacterial infections of unspecified site

2.9

6.6

100

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

1.8

6.6

531

M14.6*A52.1

ICD-10 Finland

Charcot's or tabetic arthropathy

8.7

6.5

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

4.2

6.5

WX203

NOMESCO Finland

Infraclavicular plexus blockade

2.0

6.5

360

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

1.9

6.5

381

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.4

6.5

282

2054

EJA10

NOMESCO Finland

Biopsy of tongue or floor of mouth

2.0

6.5

326

N08.2

ICD-10 Finland

Glomerular disorders in blood diseases and disorders involving the immune mechanism

6.8

6.5

B04AB02, ,

ATC

2.5

6.5

158

R04.2

ICD-10 Finland

Haemoptysis

1.8

6.5

570

R94.5

ICD-10 Finland

Abnormal results of liver function studies

2.3

6.5

195

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

1.9

6.5

389

V03AA01, ,

ATC

2.3

6.5

189

FN2AB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), drug-eluting balloon

2.4

6.5

183

K90.0

ICD-10 Finland

Coeliac disease

1.8

6.5

461

A99

ICPC

Disease/condition unspecnature/site

1.4

6.4

310

2298

U05

ICPC

Urination problems other

1.6

6.4

161

1052

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

1.8

6.4

483

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.6

6.4

139

878

25219

ICD-8 Finland

Diseases of parathyroid gland, Hypoparathyreoidismus alius sive NUD

70.0

6.4

PB1BT

NOMESCO Finland

Extensive upper extremity artery PTA

70.0

6.4

J20

ICD-10 Finland

Acute bronchitis

1.4

6.4

299

2205

S70.0

ICD-10 Finland

Contusion of hip

1.7

6.4

115

693

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

2.7

6.4

124

M02AA10

ATC

ketoprofen; topical

1.3

6.4

484

3836

L01XE26

ATC

[U] cabozantinib

14.3

6.4

3079, ,

Kela drug reimbursment

14.3

6.4

R21

ICPC

Throat symptom/complaint

1.3

6.4

577

4678

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.7

6.4

109

648

SBB20

NOMESCO Finland

Tooth X-ray examination in conjunction with visit to dentist

2.6

6.4

136

M16.5

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3020630) Protein [Mass/volume] in Serum or Plasma

985

2751

4.47

322.40

4.0

2.7

65.38

66.63

g/l

4.38

910

2518

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

659

1333

5.76

317.12

3.0

1.9

41.04

39.81

u/l

0.61

582

1193

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2963

14979

5.22

307.65

20.6

5.9

1.23

1.21

mmol/l

15.93

2855

13708

(3034860) Kappa light chains.free [Mass/volume] in Serum

653

1023

7.48

307.65

4.6

3.6

65.92

55.81

mg/l

0.45

544

873

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

648

1020

7.43

307.65

4.6

3.6

75.35

41.48

mg/l

0.73

539

874

(3020779) Urea [Moles/volume] in Serum or Plasma

1054

2726

4.94

307.65

14.9

6.7

12.20

9.34

mmol/l

25.84

1019

2614

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

588

897

7.55

307.65

4.4

3.4

6.12

3.68

ratio

0.27

333

510

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1997

5202

6.89

307.65

7.8

3.4

0.77

0.82

mmol/l

48.73

1914

4890

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

234

35.02

307.65

1.2

4.80

14.02

pmol/l

1.66

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1005

2778

4.54

307.65

2.6

2.4

381.89

371.95

nmol/l

0.73

952

2576

(3022948) Iron [Moles/volume] in Serum or Plasma

1745

5343

5.14

307.65

5.9

2.4

15.04

13.24

umol/l

13.43

1656

4983

(3004588) Protein electrophoresis panel - Serum or Plasma

894

2225

4.93

307.65

3.7

2.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1868

2298

14.82

307.65

6.4

3.5

87.18

85.43

ng/l

0.21

1592

1954

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2857

15120

4.43

307.65

4.8

2.3

75.97

78.72

nmol/l

4.99

2711

13526

(3015377) Calcium [Moles/volume] in Serum or Plasma

2374

11772

3.64

307.65

6.0

3.5

2.37

2.36

mmol/l

1.95

2197

10634

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3233

16723

6.77

307.65

25.4

6.3

1.24

1.21

mmol/l

16.88

2878

14291

(3018418) pH of Serum or Plasma

2301

9797

4.34

307.65

15.7

3.8

7.40

0.26

1892

7056

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2111

3917

10.70

307.65

11.5

5.4

1.03

mmol/l

0.42

2019

3636

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

321

248

14.03

307.65

1.4

1.2

113.48

110.51

pmol/l

0.22

321

248

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1637

4543

5.52

307.65

5.9

2.4

28.76

22.92

28.99

1556

4219

(3024561) Albumin [Mass/volume] in Serum or Plasma

2828

14847

4.39

307.65

10.7

4.8

34.29

35.71

g/l

28.90

2704

13848

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1695

4941

5.34

307.65

5.9

2.4

2.17

2.32

g/l

22.66

1607

4552

(3010838) Calcium [Moles/time] in 24 hour Urine

973

489

26.27

307.65

2.8

1.8

5.38

4.75

mmol/24h

3.21

879

434

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1129

3723

3.87

290.59

4.8

4.7

254.36

243.59

u/l

1.36

1075

3562

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

486

839

6.48

274.42

2.8

2.0

14.01

11.63

mg/l

3.98

437

782

(3021447) Carbon dioxide [Partial pressure] in Venous blood

980

3099

3.90

265.68

9.0

3.6

5.85

5.82

kpa

0.45

957

3023

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2883

17478

3.57

265.64

11.6

6.6

11.27

11.66

umol/l

0.75

2798

16646

(3012544) pH of Venous blood

972

3110

3.84

258.38

9.0

3.6

7.38

0.75

655

1746

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1795

8554

3.05

246.34

3.2

2.2

3.00

2.85

mg/l

1.50

1602

7390

(3002032) Base excess in Venous blood by calculation

932

3009

3.77

243.13

9.3

3.6

2.11

1.88

mmol/l

0.81

834

2638

(3006315) Basophils [#/volume] in Blood

2750

16893

3.19

232.98

9.0

6.3

0.04

e9/l

0.05

2465

14512

(3013115) Eosinophils [#/volume] in Blood

2798

17405

3.21

230.84

9.3

6.5

0.19

e9/l

0.68

2524

15204

(3001604) Monocytes [#/volume] in Blood

2738

16836

3.16

230.34

9.0

6.3

0.62

0.58

e9/l

4.82

2455

14458

(42870588) Differential panel, method unspecified - Blood

2088

11096

2.92

230.10

8.5

6.4

—

(3032080) INR in Blood by Coagulation assay

2552

15102

3.04

230.00

16.2

14.3

1.20

1.26

inr

7.26

2211

12546

(3023368) Bacteria identified in Blood by Culture

1817

8990

2.93

228.54

7.4

4.1

—

(3019069) Monocytes/Leukocytes in Blood

2579

15394

3.04

227.92

9.5

6.6

8.92

0.01

2466

14389

(3027945) Reticulocytes/Erythrocytes in Blood

1026

3676

3.44

226.38

3.8

2.6

1.96

1.75

7.36

936

3296

(3022096) Basophils/Leukocytes in Blood

2568

15357

3.01

224.90

9.4

6.6

0.66

0.68

1.69

2450

14335

(3006504) Eosinophils/Leukocytes in Blood

2564

15356

3.00

223.23

9.3

6.5

2.67

2.87

4.88

2453

14343

(3019198) Lymphocytes [#/volume] in Blood

2762

17239

3.12

222.71

9.2

6.3

1.78

1.91

e9/l

3.74

2514

15184

(3023520) Reticulocytes [#/volume] in Blood

873

2851

3.67

222.12

3.8

2.7

71.21

68.03

e9/l

1.40

663

2088

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2533

15155

2.96

219.34

7.1

2.9

234.86

127.54

ug/l

20.82

2406

14075

(3002030) Lymphocytes/Leukocytes in Blood

2593

15761

2.97

216.99

9.4

6.5

25.62

27.90

19.55

2499

14886

(3005719) IgG [Mass/volume] in Serum or Plasma

797

2498

3.76

215.11

3.9

2.9

10.80

10.64

g/l

0.24

741

2302

(3018010) Neutrophils/Leukocytes in Blood

2546

15441

2.91

211.73

9.0

6.4

58.86

57.15

9.73

2456

14727

(3013650) Neutrophils [#/volume] in Blood by Automated count

2913

19012

3.17

211.18

15.9

9.6

4.30

4.06

e9/l

5.67

2652

16506

(3028026) IgM [Mass/volume] in Serum or Plasma

673

1910

4.06

209.09

2.6

2.0

1.08

1.42

g/l

4.97

613

1745

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

534

1299

4.61

203.22

3.5

2.3

7.49

7.31

g/l

1.25

484

1185

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

533

1298

4.60

202.53

3.5

2.3

4.13

4.21

g/l

1.10

483

1186

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

533

1298

4.60

202.53

3.5

2.3

3.76

3.72

g/l

0.20

483

1187

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3487

25697

4.72

201.92

17.1

8.0

88.56

79.10

u/l

16.60

3423

24300

(3009343) pH of Capillary blood

685

2033

3.88

199.19

6.3

3.6

7.42

0.05

605

1668

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

902

3215

3.36

198.04

3.3

2.3

0.20

0.21

g/l

0.30

844

3022

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

694

2099

3.81

196.17

6.4

3.6

5.10

5.17

kpa

1.28

672

2025

(3037756) Immunofixation for Serum or Plasma

362

655

6.00

193.18

2.2

1.7

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

716

2235

3.71

192.97

2.3

1.6

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

619

1773

3.97

188.79

5.9

3.5

2.14

1.84

mmol/l

1.04

471

1351

(3000991) Gas panel - Venous blood

792

2679

3.46

188.33

12.8

8.4

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

121

32.84

188.10

1.0

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

499

1223

4.54

187.53

3.6

2.3

2.90

2.91

g/l

0.04

449

1112

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

624

1826

3.88

184.37

4.3

3.2

4.39

4.48

pmol/l

0.78

563

1637

(3018133) Calcium [Moles/volume] in Urine

126

26.55

182.63

2.5

2.1

2.71

mmol/l

0.00

119

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1913

10623

2.59

179.26

3.9

2.5

61.31

61.00

u/l

0.04

1814

9791

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

521

1379

4.21

176.65

2.0

1.7

1.57

1.51

g/l

0.62

456

1200

(3015235) Bicarbonate [Moles/volume] in Capillary blood

444

1040

4.69

176.27

4.5

2.7

24.54

25.06

mmol/l

1.54

434

1025

(3024354) Oxygen [Partial pressure] in Venous blood

768

2649

3.37

176.11

7.1

3.1

4.72

4.56

kpa

1.02

742

2584

(3013826) Glucose [Moles/volume] in Serum or Plasma

2861

19408

2.84

175.13

9.9

4.5

6.81

6.62

mmol/l

5.38

2788

18319

(3020876) Protein [Mass/time] in 24 hour Urine

245

327

7.93

174.09

3.1

2.3

0.90

1.23

g/24h

0.75

182

178

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

412

917

4.91

174.00

5.3

4.0

1.91

1.45

mg/l

13.75

388

834

(3026493) Urate [Moles/volume] in Serum or Plasma

1636

8538

2.59

173.09

4.7

2.6

369.63

338.38

umol/l

22.56

1483

7494

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

456

1122

4.48

169.94

3.8

2.4

0.96

1.06

g/l

0.13

373

964

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

761

2675

3.30

168.64

13.2

3.3

1.24

1.23

mmol/l

1.43

709

2259

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

452

1121

4.43

166.63

3.6

2.3

9.67

10.39

g/l

2.25

397

997

(3012565) Volume of 24 hour Urine

161

129

12.98

165.68

2.9

2.3

2109.09

1890.74

1.02

154

117

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1165

5359

2.68

156.92

2.5

1.8

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

579

1817

3.57

152.72

8.6

4.0

24.16

24.31

mmol/l

0.41

573

1802

(3003181) Sodium [Moles/volume] in Urine

223

315

7.45

150.57

2.1

1.2

59.46

69.49

mmol/l

2.26

188

249

(1616796) Gas panel - Central venous blood

322

655

5.27

150.55

5.5

3.7

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

380

892

4.62

149.78

1.6

1.3

—

(3026782) Osmolality of Urine

1257

6124

2.56

149.25

4.3

2.7

492.96

541.39

mosm/kgh2o

12.98

1152

5345

(3023183) Ammonium ion [Moles/volume] in Plasma

307

615

5.34

145.96

3.9

2.9

34.99

35.09

umol/l

0.02

275

567

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1327

6761

2.47

141.81

4.7

3.1

2.51

2.45

mmol/l

14.08

1193

6116

(3007164) IgA [Mass/volume] in Serum or Plasma

1287

6475

2.48

141.29

2.2

1.5

2.67

2.46

g/l

1.15

904

3930

(3002582) Erythrocytes [#/volume] in Urine

1826

10744

2.33

139.97

5.3

3.1

65.82

97.91

e6/l

0.72

1501

8180

(3021901) Oxygen saturation in Capillary blood

294

588

5.33

139.94

4.5

2.6

89.72

90.21

0.46

287

574

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1822

10723

2.33

139.43

4.9

3.2

34.58

34.47

u/l

0.03

1732

10066

(3028626) Oxygen [Partial pressure] in Capillary blood

338

768

4.73

138.46

5.2

3.4

8.18

8.35

kpa

0.89

330

754

(3010421) pH of Blood

398

1030

4.19

137.93

6.5

3.5

7.41

0.37

390

1022

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

375

938

4.32

135.92

3.7

2.3

0.03

g/l

0.06

321

845

(21494890) Protein electrophoresis panel - 24 hour Urine

205

296

7.26

135.59

2.8

2.1

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1697

9797

2.31

134.61

2.8

2.1

268.40

214.58

u/l

0.56

1630

9232

(3026008) Bacteria identified in Urine by Culture

1711

9979

2.28

131.67

4.3

3.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

362

906

4.31

130.99

3.7

2.3

0.00

g/l

0.50

298

795

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

300

647

4.94

130.73

7.9

5.3

709.95

3087.60

iu/ml

0.42

(3004119) Hemoglobin [Mass/volume] in Venous blood

558

1880

3.30

130.47

7.1

3.0

120.67

129.60

g/l

15.91

545

1824

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1669

9683

2.28

129.51

3.7

3.0

2523.84

1183.26

ng/l

7.86

1457

8294

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1003

4655

2.56

129.16

2.5

2.0

29.55

29.57

0.04

976

4521

(3014111) Lactate [Moles/volume] in Serum or Plasma

712

2799

2.89

127.05

10.1

7.4

1.44

1.32

mmol/l

1.20

696

2752

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

136

127

11.06

126.66

7.7

6.7

5.02

162.52

ug/l

0.60

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

885

3907

2.64

126.02

2.2

1.7

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

435

1276

3.72

126.00

2.6

1.9

2.53

2.61

ug/l

0.03

398

1139

(3000850) Epithelial cells [#/volume] in Urine

1389

7532

2.32

125.86

4.3

2.5

5.13

5.69

e6/l

1.05

1300

6806

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

587

2083

3.14

125.59

9.9

8.5

24.68

24.98

mmol/l

0.97

578

2074

(3018095) Leukocytes [#/volume] in Urine

1957

12228

2.22

125.26

6.3

3.6

127.44

108.12

e6/l

0.40

1548

8608

(3019309) Folate [Moles/volume] in Red Blood Cells

1111

5521

2.42

122.46

2.0

1.7

1301.72

1165.98

nmol/l

3.43

877

4178

(3017181) Myelocytes/Leukocytes in Blood

743

3060

2.77

120.95

5.5

4.3

0.91

0.93

0.11

346

883

(3030467) Casts [#/volume] in Urine by Automated count

1601

9327

2.23

120.81

4.9

3.0

0.58

0.41

e6/l

1.59

1263

6839

(3027273) Bicarbonate [Moles/volume] in Venous blood

439

1341

3.57

119.42

8.6

2.9

25.49

25.43

mmol/l

0.10

424

1296

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

3188

24708

2.67

118.19

6.7

4.3

17.44

11.93

mm/h

44.45

3037

23008

(3016502) Oxygen saturation in Arterial blood

762

3219

2.70

117.76

9.2

7.7

94.76

95.71

2.38

738

3116

(3021960) Folate [Moles/volume] in Serum or Plasma

1617

9557

2.19

116.64

2.2

1.6

19.53

20.52

nmol/l

1.31

1396

7924

(3019977) pH of Arterial blood

825

3642

2.61

116.55

9.1

7.4

7.41

7.42

0.56

471

2008

(3037467) Urinalysis macro (dipstick) panel - Urine

2998

22720

2.43

114.29

7.2

4.4

—

2.83

—

(3003396) Base excess in Arterial blood by calculation

815

3609

2.60

114.18

9.0

7.3

0.87

0.99

mmol/l

0.27

690

2955

(3002179) Metamyelocytes/Leukocytes in Blood

709

2934

2.74

113.78

5.3

4.2

0.89

0.71

0.73

333

845

(3021440) Promyelocytes/Leukocytes in Blood

707

2930

2.73

113.08

5.6

4.4

0.16

0.11

1.12

312

761

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

325

838

4.14

112.63

3.9

2.4

0.00

g/l

-0.00

298

794

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2270

15441

2.14

112.18

4.0

2.7

—

estimate

—

(3044640) Blood type and Crossmatch panel - Blood

1745

10744

2.14

112.08

3.7

2.4

—

(3027801) Oxygen [Partial pressure] in Arterial blood

815

3653

2.56

111.04

9.2

7.4

11.58

12.57

kpa

6.92

792

3509

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

815

3653

2.56

111.04

9.2

7.4

5.06

5.13

kpa

0.99

791

3513

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

808

3624

2.56

109.81

2.3

1.8

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1933

12455

2.11

109.21

5.6

3.3

45.07

88.41

ng/l

0.61

1571

8734

(3025159) Blasts/Leukocytes in Blood

706

2976

2.68

108.87

5.5

4.6

0.05

0.36

1.40

298

726

(3002173) Hemoglobin [Mass/volume] in Arterial blood

705

2976

2.68

108.37

9.9

8.3

116.08

121.42

g/l

8.26

690

2904

(36304419) Bacteria [Presence] in Urine

1505

8846

2.15

108.06

4.6

3.0

0.00

359.65

estimate

—

(3042936) Bacteria identified in Isolate by Culture

947

4627

2.39

106.40

2.7

2.0

—

(3022313) Gas panel - Capillary blood

443

1472

3.27

104.96

6.4

3.9

—

(3031040) Bacteria [#/volume] in Urine by Automated count

2878

21758

2.27

104.92

6.9

4.5

3841.26

1743.28

e6/l

0.49

258

(3037121) Protein [Mass/volume] in Urine

370

1099

3.62

104.59

4.1

3.1

819.56

444.30

mg/l

0.50

208

461

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

160

236

7.03

103.59

7.0

4.6

68.30

92.63

u/ml

0.19

(40767503) Oxygen content in Capillary blood by calculation

273

658

4.39

103.27

4.1

2.2

15.49

16.64

5.60

263

645

(3037522) Nuclear Ab [Titer] in Serum

930

4565

2.37

102.98

1.5

1.3

438.99

531.11

titre

0.99

199

997

(3017143) Hepatitis C virus Ab [Presence] in Serum

761

3444

2.51

100.65

2.2

1.5

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

284

725

4.15

99.53

2.0

1.6

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

235

519

4.76

99.13

4.1

3.1

10394.86

1596.40

u/ml

0.42

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2160

14850

2.03

98.36

2.7

2.0

95.90

96.76

pmol/l

0.34

1263

7748

(3033658) Prothrombin time (PT) actual/Normal

1384

8150

2.09

96.35

7.0

4.0

89.90

89.47

0.26

1354

7964

(40760892) CBC W Ordered Manual Differential panel - Blood

1299

7494

2.11

95.33

7.1

4.7

—

(3017704) Immunofixation for Urine

122

146

8.60

94.51

1.7

1.6

—

(3035350) Ketones [Presence] in Urine by Test strip

2444

17743

2.03

93.30

5.7

3.8

6.83

2.66

estimate

0.51

709

3830

(40768446) Kidney Pathology biopsy report

100

11.01

93.27

1.8

1.5

—

(3026250) Tacrolimus [Mass/volume] in Blood

109

115

9.72

93.01

48.0

38.1

7.08

7.26

ug/l

0.26

102

104

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

886

4428

2.30

92.94

2.2

1.6

—

(3000012) Reticulocyte production index

206

431

4.99

92.63

2.1

2.2

0.83

0.89

0.72

157

285

(3021601) Nitrite [Presence] in Urine by Test strip

2421

17553

2.02

92.30

5.6

3.8

0.00

estimate

1.08

695

3721

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

11.28

91.98

1.7

1.6

0.47

0.37

ug/l

0.79

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

437

1560

3.03

91.16

7.9

3.4

47.87

48.17

0.08

424

1534

(3009261) Glucose [Presence] in Urine by Test strip

2444

17882

2.00

89.46

5.7

3.8

0.01

0.37

estimate

0.66

678

3616

(3009508) Creatinine [Moles/volume] in Urine

1745

11398

1.97

88.92

4.8

3.2

6.74

7.62

mmol/l

15.09

1536

9513

(3011985) Renin [Units/volume] in Plasma

188

381

5.14

87.68

2.2

1.4

49.19

61.84

mu/l

0.29

168

339

(4035726) Immunohistochemistry procedure

672

3045

2.46

87.62

1.6

1.4

—

(3021589) Normoblasts [#/volume] in Blood

2128

14918

1.95

87.44

23.3

10.9

0.00

e9/l

0.43

1806

12241

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2808

21703

2.08

86.56

5.4

3.2

71.37

47.04

u/l

17.91

2674

20249

(3009445) Proteinase 3 Ab [Units/volume] in Serum

388

1344

3.10

85.09

1.4

1.6

2.46

16.88

iu/ml

—

(3004809) Band form neutrophils/Leukocytes in Blood

227

550

4.32

85.07

3.6

3.7

1.89

1.62

0.34

208

487

(3016038) Potassium [Moles/volume] in Urine

100

106

9.66

85.01

2.3

1.3

34.41

37.61

mmol/l

0.51

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

317

976

3.45

84.35

3.7

3.1

0.31

0.34

iu/ml

1.16

163

526

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

283

817

3.66

83.06

2.0

1.6

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3138

25478

2.24

82.43

7.1

4.2

15.32

14.80

pmol/l

23.27

2956

23232

(3007853) Bacteria identified in Skin by Aerobe culture

771

3803

2.28

82.38

2.1

1.7

—

(3012501) Base excess in Blood by calculation

246

652

3.96

81.65

5.6

3.9

2.94

2.65

mmol/l

0.79

191

448

(3013290) Carbon dioxide [Partial pressure] in Blood

246

653

3.96

81.47

5.7

3.9

5.02

5.04

kpa

0.08

238

643

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

435

1647

2.85

81.19

6.4

2.9

0.64

0.62

0.48

435

1640

(3027315) Oxygen [Partial pressure] in Blood

247

660

3.93

81.04

5.7

4.0

8.78

8.51

kpa

1.42

239

650

(3047189) Immunofixation for 24 hour Urine

110

140

8.06

80.98

2.7

1.9

—

(3007566) Smooth muscle Ab [Titer] in Serum

297

903

3.48

80.52

1.3

1.2

143.06

103.69

titre

0.48

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

208

504

4.31

77.88

1.4

1.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

234

623

3.93

77.12

2.0

1.4

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1243

7525

1.96

76.31

1.4

1.3

1.02

1.81

u/ml

2.61

344

2006

(3020682) Albumin/Creatinine [Ratio] in Urine

1640

10892

1.88

75.82

5.8

3.9

29.43

6.66

mg/mmol

1.73

1172

6502

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1327

8248

1.93

75.07

3.7

2.3

—

(3028271) Lactate [Moles/volume] in Capillary blood

204

501

4.24

75.02

2.7

1.6

1.78

1.67

mmol/l

0.69

196

487

(3015736) pH of Urine

1972

13920

1.85

74.72

4.7

3.4

6.27

6.24

0.44

1113

7816

(3034770) Mitochondria Ab [Titer] in Serum

286

893

3.38

74.25

1.3

1.2

815.00

1163.21

titre

—

(3024928) Oxygen saturation in Venous blood

255

742

3.61

73.83

5.6

3.4

62.62

61.58

0.28

245

725

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

731

3688

2.21

73.10

4.7

2.9

9.46

8.57

umol/l

0.42

640

3243

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

367

1339

2.92

73.08

7.2

4.8

1.62

1.60

0.13

351

1258

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

320

1082

3.13

72.84

2.4

2.1

690.67

581.24

ug/l

0.14

302

1027

(3042111) Morphology [Interpretation] in Bone marrow Narrative

210

539

4.06

72.77

1.6

1.7

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

280

874

3.38

72.70

2.1

1.6

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

698

3467

2.24

72.48

5.4

3.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

303

1004

3.19

71.34

1.5

1.4

247.37

280.85

ug/g

1.68

184

576

(3006184) Hemoglobin [Mass/volume] in Capillary blood

247

720

3.60

71.29

3.6

2.1

123.20

130.13

g/l

3.44

213

537

(3044927) Protein electrophoresis panel - Urine

153

311

5.08

71.03

1.2

1.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

430

1730

2.67

71.02

11.7

10.0

15.16

16.05

7.14

418

1656

(3012516) Albumin [Mass/volume] in Urine

1605

10747

1.85

70.95

4.9

3.3

94.85

39.97

mg/l

9.99

1181

6595

(46235355) HIV 1 and 2 tests - Meaningful Use set

918

5108

2.05

70.81

2.3

1.8

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

227

632

3.75

70.11

1.9

1.3

19.39

16.83

u/ml

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

460

1925

2.58

70.10

8.1

6.7

24.67

24.63

mmol/l

0.06

444

1842

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

706

3582

2.19

69.28

3.9

4.4

34.22

27.30

ug/l

0.29

593

2910

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

260

799

3.42

69.14

2.2

1.8

4.14

3.68

iu/l

0.35

123

292

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

211

565

3.89

68.90

1.9

1.4

137.19

148.79

au/ml

0.61

161

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

402

1587

2.71

68.84

1.8

1.4

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1168

7147

1.91

67.92

2.0

1.7

1.53

1.28

mg/l

1.77

925

5473

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

283

927

3.22

67.85

1.6

1.3

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

137

263

5.36

67.84

2.3

1.8

6.30

3.62

mg/l

6.12

128

253

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

149

308

4.99

67.83

1.4

1.2

69.14

60.50

u/l

0.57

139

268

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

322

1151

2.96

66.37

1.3

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

160

361

4.58

65.54

1.4

1.3

1087.95

289.75

pmol/l

0.65

133

312

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

329

1199

2.91

65.45

6.8

3.9

24.95

24.89

mmol/l

0.11

313

1125

(3019225) pH of Specimen

671

3408

2.17

65.34

14.6

3.7

7.38

7.35

6.18

590

2378

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

212

592

3.73

65.15

1.7

1.2

277.18

275.94

u/ml

0.02

129

352

(3007930) Methemoglobin/Hemoglobin.total in Blood

332

1230

2.86

64.04

7.5

5.0

0.88

0.89

0.10

318

1149

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

891

5067

1.99

63.77

4.5

3.0

3.23

2.59

e6/l

1.02

465

2443

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

212

601

3.67

63.71

2.2

1.7

—

(40768797) Stomach Pathology biopsy report

826

4582

2.02

63.39

1.3

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

329

1222

2.85

63.14

2.2

1.7

0.42

0.31

mg/l

1.96

174

561

(3021879) Hepatitis B virus core Ab [Presence] in Serum

505

2310

2.36

63.11

1.6

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

163

400

4.21

59.92

1.7

1.5

—

(3029937) Albumin [Presence] in Urine by Test strip

1493

10155

1.77

59.77

5.8

3.9

0.00

estimate

1.85

630

3477

(3030981) Hyaline casts [#/volume] in Urine by Automated count

542

2627

2.24

58.85

4.2

2.2

0.45

0.41

e6/l

0.16

527

2511

(3002079) Sodium [Moles/time] in 24 hour Urine

114

7.51

58.51

1.8

1.3

159.58

157.51

mmol/24h

0.07

114

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1129

7110

1.83

58.31

2.0

1.7

481.79

38433460.95

pmol/l

6.53

933

5935

(3019060) Gas panel - Arterial blood

433

1920

2.41

57.80

5.8

4.6

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

955

5721

1.89

57.74

4.0

2.8

1.20

1.12

e6/l

0.22

533

3094

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

165

422

4.04

57.37

1.7

1.5

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

450

2037

2.37

57.32

10.7

9.3

0.64

0.65

0.21

445

2027

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

171

457

3.87

55.92

8.0

6.6

13.12

11.78

mg/l

2.97

152

422

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

261

915

2.99

55.51

2.5

1.6

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1384

9365

1.75

55.35

5.2

3.2

0.52

0.24

estimate

0.28

600

2957

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

164

436

3.88

54.02

1.2

1.3

0.21

0.36

nmol/l

0.72

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

191

566

3.50

53.62

1.3

28.08

37.95

u/l

0.86

173

481

(40768441) Liver Pathology biopsy report

116

237

5.02

53.51

1.6

1.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

264

953

2.90

53.23

1.6

1.2

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

453

2121

2.29

53.17

10.7

9.0

1.34

1.31

0.23

448

2113

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

119

250

4.88

53.13

1.7

1.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1826

13444

1.68

52.70

5.6

3.7

0.88

0.55

estimate

0.15

605

3083

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

159

421

3.90

52.67

1.2

1.3

0.66

4.82

nmol/l

0.49

153

406

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

415

1883

2.35

52.38

2.0

1.6

—

(3008295) Osmolality of Serum or Plasma

120

259

4.75

51.88

1.5

1.4

277.66

285.43

mosm/kgh2o

2.34

103

193

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

411

1870

2.34

51.52

10.9

9.2

23.82

24.35

mmol/l

2.02

400

1833

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

203

644

3.27

51.13

1.6

1.4

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3595

32420

2.60

50.84

37.1

14.6

25.00

24.42

mg/l

0.53

3296

26459

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

295

1163

2.66

50.23

2.7

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

133

321

4.26

49.96

2.5

25.97

29.37

iu/ml

0.17

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

13.68

49.36

16.9

9.1

4.70

5.89

mmol/l

1.61

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

223

766

3.03

49.09

1.7

1.4

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

185

569

3.36

48.97

1.3

292.50

420.37

titre

0.26

(3042733) HLA Ab [Presence] in Serum

7.76

48.86

5.9

4.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

104

7.04

47.44

3.0

0.59

0.61

mmol/l

1.45

104

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

105

219

4.90

47.29

1.2

84.30

80.56

0.24

(3017354) Segmented neutrophils/Leukocytes in Blood

141

373

3.89

46.76

3.2

4.0

63.50

57.07

2.60

123

315

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

123

297

4.24

46.18

1.3

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

256

980

2.73

46.12

1.7

1.18

g/l

0.11

245

947

(3040151) Glucose [Moles/volume] in Capillary blood

128

319

4.12

46.08

7.2

24.3

7.07

6.99

mmol/l

0.10

119

265

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

139

370

3.86

45.70

1.2

1.3

0.20

0.18

nmol/l

1.17

108

302

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

246

928

2.76

45.58

2.8

2.7

3.55

3.50

g/l

0.15

235

887

(3045142) Bone marrow Pathology biopsy report

137

362

3.89

45.51

1.5

1.3

—

(40761536) Microorganisms panel - Urine sediment

527

2781

2.04

45.16

5.7

3.7

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

248

946

2.73

44.97

1.7

0.25

0.23

g/l

1.36

236

914

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

194

5.05

44.86

1.7

1.6

6.19

6.20

u/l

0.00

161

(3018405) Lactate [Moles/volume] in Arterial blood

266

1053

2.64

44.83

4.1

3.8

1.50

1.31

mmol/l

1.23

258

1046

(3011412) CD3 cells [#/volume] in Blood

121

296

4.19

44.66

2.5

1070.00

1143.31

e6/l

0.40

109

262

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3400

30278

2.04

44.44

8.7

5.1

1.94

1.93

mu/l

0.19

3226

27791

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

195

659

3.06

44.13

1.7

1.4

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

154

451

3.52

43.99

1.1

1.56

1.51

g/l

0.67

145

408

(3020891) Body temperature

345

1559

2.33

43.70

7.3

4.2

36.93

36.91

°c

0.46

338

1545

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

169

528

3.30

43.61

1.7

1.4

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

175

5.18

42.91

1.3

1.1

105.55

85.23

u/l

0.63

158

(3022806) Fractional oxyhemoglobin in Capillary blood

141

396

3.66

42.90

2.6

1.5

90.09

89.90

0.13

135

389

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

180

5.10

42.56

1.5

1.4

—

(3047181) Lactate [Moles/volume] in Blood

228

862

2.75

42.03

7.9

5.8

1.44

1.26

mmol/l

1.20

204

752

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

222

832

2.77

41.62

1.3

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

176

5.03

40.61

1.5

1.4

—

(3025941) Bacteria identified in Stool by Culture

352

1658

2.24

40.31

1.5

1.2

—

(3000494) Fungus identified in Specimen by Culture

682

4062

1.82

40.27

1.9

1.5

—

(3008037) Lactate [Moles/volume] in Venous blood

198

712

2.88

40.09

5.0

2.6

1.59

1.65

mmol/l

0.31

192

687

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

175

5.00

39.88

1.3

1.1

52.30

24.77

u/l

1.22

158

(1175426) CD3 cells/Lymphocytes in Blood

101

240

4.29

38.74

2.3

2.4

74.41

71.89

0.70

228

(3019550) Sodium [Moles/volume] in Serum or Plasma

3633

33502

2.45

38.57

44.2

16.8

139.25

139.80

mmol/l

30.47

3607

32805

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

10.60

38.43

1.7

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

143

438

3.35

38.09

2.0

20.62

26.33

ug/l

0.85

136

433

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

211

811

2.69

37.64

3.9

3.6

1454.68

855.59

u/ml

0.31

198

738

(3000093) Morphology [Interpretation] in Blood Narrative

113

299

3.86

37.48

1.2

1.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

3634

33569

2.43

37.47

45.1

16.9

3.97

mmol/l

0.16

3606

32801

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

220

4.35

36.78

1.8

1.5

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

909

6007

1.67

36.74

5.1

3.5

278.99

590.59

ng/l

1.04

739

4645

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

225

4.30

36.60

2.3

2.4

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

125

361

3.55

36.49

1.3

—

nmol/l

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

608

3598

1.82

36.35

2.3

1.7

1.73

1.46

9.80

507

3174

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

207

4.43

36.00

1.8

1.5

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

12.61

35.78

6.3

5.6

56.76

45.82

ug/min

0.23

(3017732) Neutrophils [#/volume] in Blood

697

4315

1.75

35.69

3.8

3.1

4.50

4.48

e9/l

0.03

582

3727

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

110

5.90

35.67

1.1

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

9.86

35.65

3.0

2.5

52.58

22.04

mg/l

0.71

(3014051) Protein [Presence] in Urine by Test strip

1244

8962

1.57

34.98

4.1

2.8

0.15

0.03

0.75

238

(40768804) Tissue Pathology biopsy report

1755

13651

1.52

34.74

2.4

2.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

166

4.78

34.34

1.4

1.3

31.68

22.99

u/l

0.60

135

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

174

4.67

34.31

1.5

1.2

95.40

89.71

u/l

0.16

145

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

8.27

34.21

5.0

3.9

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

203

4.36

34.18

1.8

1.5

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

266

1199

2.31

33.71

2.3

1.8

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

131

416

3.22

32.93

1.7

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

133

427

3.19

32.84

1.7

1.4

—

(3024471) HLA-A [Type]

6.16

32.68

1.0

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

184

709

2.68

32.65

1.7

1.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

114

334

3.49

32.57

3.8

4.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

280

1311

2.22

32.39

2.9

1.9

—

(3035933) Granulocytes/Leukocytes in Blood

188

737

2.63

32.23

4.5

3.2

60.29

57.74

1.82

188

737

(3024522) Salmonella sp identified in Specimen by Organism specific culture

131

423

3.17

32.04

1.7

1.4

—

(3048689) Calprotectin [Mass/mass] in Stool

670

4232

1.71

31.54

2.5

2.4

150.97

134.13

ug/g

0.73

534

3320

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

238

1052

2.35

31.54

1.8

1.5

0.35

3.42

iu/ml

0.45

186

(3024932) HLA-DR beta [Type]

6.05

31.53

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

132

5.07

31.25

1.6

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

132

5.07

31.25

1.6

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

125

401

3.19

30.91

1.8

1.4

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

225

3.98

30.65

1.7

1.3

0.92

1.24

promille

1.07

179

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

125

404

3.16

30.53

1.8

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

125

406

3.15

30.28

1.8

1.4

—

(40758558) Short blood count panel - Blood

1345

10102

1.51

30.19

10.7

6.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

6.32

29.95

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

100

287

3.55

29.50

3.4

2.7

—

(3042631) Mycobacterium sp identified in Specimen

132

450

3.00

29.43

2.7

3.1

—

(3010375) cycloSPORINE [Mass/volume] in Blood

134

4.84

28.75

28.0

24.6

102.76

119.32

ug/l

1.00

109

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

388

2140

1.90

28.63

1.2

177.17

130.79

u/ml

0.97

150

793

(21494814) CD8 cells/Lymphocytes in Specimen

128

4.91

28.32

2.3

2.0

38.97

28.77

3.52

128

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

505

3033

1.77

28.24

4.1

2.4

40.70

55.39

u/l

0.43

428

2551

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

470

2764

1.80

28.24

4.5

2.5

49.91

67.51

ml/min/173m2

18.33

266

1115

(3022145) Colonoscopy Study observation

611

3884

1.68

27.79

1.5

1.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

246

3.68

27.78

1.7

1.2

—

(3004451) EKG impression Narrative

152

4.47

27.32

1.5

1.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2277

19201

1.45

27.14

3.4

2.8

—

(3023420) DNA double strand Ab [Units/volume] in Serum

273

1377

2.06

25.99

1.9

1.8

7.77

7.03

iu/ml

0.14

326

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

168

693

2.49

25.93

1.3

1.2

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

3416

31502

1.74

25.85

35.1

14.2

72.75

80.32

ml/min/173m2

55.25

3285

29135

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

204

924

2.28

25.52

1.6

1.3

—

(3003694) ABO and Rh group [Type] in Blood

1236

9370

1.47

25.44

1.6

1.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

147

575

2.62

25.33

3.2

1.9

1.02

0.82

nmol/l

2.12

119

489

(36660697) Celiac disease serology panel - Serum

434

2578

1.77

25.07

1.2

—

(3038515) Glucose [Moles/volume] in Venous blood

149

593

2.57

24.79

5.7

2.8

7.33

7.38

mmol/l

0.07

144

573

(3009214) Lutropin [Units/volume] in Serum or Plasma

186

825

2.32

24.44

1.7

1.4

11.74

10.18

u/l

0.59

148

663

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

437

2639

1.74

23.77

2.6

2.2

5.04

7.26

ug/l

3.29

370

2333

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

109

377

2.95

23.74

2.4

1.7

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

273

3.31

23.73

1.2

65.00

166.81

titre

—

(21494434) Karyotype in Bone marrow

299

3.20

23.63

1.1

1.2

—

(3039000) Anion gap in Blood by calculation

148

605

2.50

23.30

9.9

6.9

11.81

11.19

mmol/l

1.15

137

532

(3018572) Chloride [Moles/volume] in Blood

148

606

2.50

23.22

9.9

6.9

104.61

105.11

mmol/l

0.46

137

533

(3024980) IgG subclass 4 [Mass/volume] in Serum

139

553

2.57

23.16

1.6

1.7

0.73

0.81

g/l

0.31

435

(3036489) Thrombin time

230

1142

2.08

22.83

2.3

2.1

21.12

20.90

0.33

208

1003

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

241

1218

2.04

22.80

2.8

3.7

926.68

1513.75

u/ml

0.25

213

1041

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

291

3.18

22.69

2.6

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

291

3.18

22.69

2.6

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

291

3.18

22.69

2.6

1.6

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

199

3.67

22.53

2.4

2.5

0.51

0.66

e9/l

1.58

192

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

137

4.28

22.51

3.7

2.7

1.17

1.35

0.33

137

(3017569) Oxygen content in Arterial blood

163

3.98

22.48

2.5

14.79

16.37

2.47

163

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

200

3.65

22.37

2.6

2.8

493.79

494.11

e6/l

0.00

163

(3045424) Erythrocytes [Presence] in Urine

313

1742

1.87

22.32

3.0

2.1

0.00

0.48

estimate

0.51

526

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

189

877

2.21

22.31

2.6

213.79

191.75

2.22

179

835

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

134

4.30

22.26

1.3

1.7

3.04

6.69

nmol/l

0.51

106

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

126

4.41

22.20

2.4

1.7

38.03

40.47

g/l

1.90

126

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

101

349

2.94

22.05

2.4

1.7

—

(40768795) Lymph node Pathology biopsy report

100

347

2.93

21.67

1.5

1.2

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

206

3.54

21.42

2.8

2.9

213.85

223.27

e6/l

0.12

177

(3044242) Glucose [Moles/volume] in Arterial blood

154

3.94

20.87

2.4

2.1

7.65

8.43

mmol/l

0.76

154

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

275

3.14

20.81

1.8

1.5

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

177

3.72

20.81

2.9

39.36

40.69

0.21

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

161

722

2.28

20.64

1.3

3.88

3.66

mmol/l

1.39

151

680

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

149

650

2.34

20.37

3.4

2.2

239.71

109.18

ug/min

1.12

373

(3014148) Varicella zoster virus Ab [Titer] in Serum

103

376

2.79

20.36

1.1

—

(3016750) Collection duration of Urine

148

3.96

20.34

3.3

2.0

503.37

493.45

min

0.27

104

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

300

3.01

20.32

1.5

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

127

517

2.51

20.21

1.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

846

6201

1.47

19.84

1.4

1.3

44.10

31.56

iu/ml

1.10

244

1831

(3006922) Hepatitis E virus Ab [Presence] in Serum

243

3.21

19.66

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

7.12

19.49

1.5

1.2

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

5.04

19.48

1.8

1.4

14.57

15.22

pmol/l

0.37

(44790048) Parainfluenza type 2 nucleic acid detection

107

410

2.66

19.28

1.7

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

107

410

2.66

19.28

1.7

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

107

410

2.66

19.28

1.7

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

107

410

2.66

19.28

1.7

1.4

—

(3004775) Volume in Urine collected for unspecified duration

206

3.39

19.26

3.0

2.1

725.87

655.21

0.67

129

(3011397) Hemoglobin [Presence] in Urine by Test strip

1045

8010

1.42

19.13

5.1

3.8

1.40

0.62

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

237

3.21

19.12

1.3

2.21

2.15

mmol/l

0.11

224

(3015171) Extractable nuclear Ab [Units/volume] in Serum

240

1290

1.92

19.02

1.3

1.2

0.32

1.17

u/ml

1.67

104

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

352

2.77

18.84

1.3

1.1

—

3.37

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

390

2430

1.67

18.75

3.7

2.8

255.47

184.52

ng/l

1.40

350

2214

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

173

832

2.13

18.69

1.3

1.4

464.49

563.54

mg/l

2.79

163

788

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

138

605

2.33

18.67

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

138

605

2.33

18.67

1.3

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3651

34813

1.91

18.35

47.4

19.1

98.18

76.47

umol/l

57.55

3633

34366

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

161

3.64

18.09

3.2

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

161

3.64

18.09

3.2

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

161

3.64

18.09

3.2

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

161

3.64

18.09

3.2

1.9

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

350

2.73

17.93

1.3

1.2

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

118

4.11

17.74

1.9

2.1

951.50

2349.43

u/ml

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

36.87

17.59

5.8

1.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

148

688

2.20

17.43

1.8

1.6

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

780

5753

1.45

17.42

1.4

1.3

9.64

10.90

u/ml

0.23

297

2244

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3619

34476

1.81

17.34

23.0

11.6

26.42

25.92

u/l

0.97

3568

33372

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

108

439

2.50

17.28

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

184

934

2.02

17.22

2.0

1.7

309.95

295.28

mu/l

0.28

168

862

(3002256) Pathology report gross observation

651

4657

1.48

17.00

1.3

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

2928

26747

1.39

16.58

43.7

18.0

14.16

13.62

63.44

2915

26347

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

120

525

2.33

16.35

1.2

1.1

1.05

0.87

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

181

931

1.99

16.33

1.9

1.4

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

6.54

16.19

1.0

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

418

2750

1.58

16.06

2.6

2.2

13.06

13.73

nmol/l

0.84

371

2504

(3034988) Calcium [Moles/volume] in Capillary blood

5.99

16.04

2.5

1.5

1.19

1.18

mmol/l

0.27

(3044290) Cell count panel - Cerebral spinal fluid

139

657

2.16

15.73

1.4

1.5

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

121

3.84

15.54

2.0

2.5

161.13

133.58

umol/l

0.15

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

146

707

2.11

15.53

1.4

1.5

16.56

29.79

e6/l

0.51

107

537

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

119

531

2.28

15.51

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

247

2.91

15.42

1.3

1.1

—

(3049717) Cytology report of Urine Cyto stain

218

1217

1.84

15.37

2.2

2.7

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

332

2.63

15.34

1.3

7.10

6.87

g/l

0.18

240

(3024139) IgG subclass 3 [Mass/volume] in Serum

332

2.63

15.34

1.3

0.48

0.41

g/l

0.29

239

(3028192) IgG subclass 2 [Mass/volume] in Serum

332

2.63

15.34

1.3

2.67

2.99

g/l

0.77

242

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

268

1592

1.73

15.32

1.1

1.18

0.88

u/ml

—

(4062490) Immunoglobulin typing, IgG

322

2.64

15.20

1.3

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

147

720

2.08

15.18

1.4

1.5

1056.43

1363.04

e6/l

0.15

119

578

(40757494) Bilirubin.total [Moles/volume] in Blood

166

3.35

15.16

4.2

2.2

15.20

31.40

umol/l

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

128

3.70

15.12

1.2

4.3

3569.64

61.76

mg/l

0.49

(37021550) Renin [Units/volume] in Plasma --upright

5.12

15.03

1.6

1.3

171.58

44.87

mu/l

0.89

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

4.30

14.99

1.7

1.5

3395.25

22875.59

e6/l

0.50

(3052851) Hemolysis interference index of Serum or Plasma

161

827

1.99

14.61

4.2

3.1

2.70

1.97

index

0.47

425

(3020911) Cortisol [Moles/time] in 24 hour Urine

4.37

14.49

1.4

1.3

85.92

157.50

nmol/24h

0.45

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

189

1030

1.88

14.39

1.3

47.83

31.43

u/ml

0.24

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

5.03

14.29

1.2

1.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

124

3.66

14.25

3.6

2.0

—

(3003434) Protein [Mass/volume] in Pleural fluid

104

456

2.32

14.15

1.5

1.4

31.40

33.26

g/l

0.70

421

(3026389) Candida sp identified in Specimen by Organism specific culture

103

450

2.32

14.13

1.9

1.4

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

383

2.44

14.06

1.3

1.4

31.85

28.75

u/l

0.30

317

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

4.67

13.98

1.2

405.42

289.73

pmol/l

0.53

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3287

30895

1.43

13.67

8.8

5.9

39.96

38.76

mmol/mol

10.28

3074

28664

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

123

3.61

13.65

3.6

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

123

3.61

13.65

3.6

2.1

—

(3045414) Leukocytes [Presence] in Urine

479

3358

1.49

13.65

2.8

2.0

0.03

0.01

estimate

0.43

108

659

(3023419) Bacteria identified in Sputum by Culture

101

449

2.28

13.33

2.9

2.7

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

107

3.77

13.23

1.8

1.9

916.60

648.13

e6/l

0.19

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

176

3.10

13.18

1.1

1.4

17.97

5.81

u/l

0.45

155

(1761482) Bacteria [#/volume] in Urine by Culture

141

718

2.00

13.14

5.0

4.3

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3342

31572

1.44

12.90

6.4

5.0

6.10

5.88

mmol/l

13.98

3073

28757

(3006571) Granulocytes/Leukocytes in Synovial fluid

384

2.35

12.60

2.1

1.6

69.85

58.52

2.12

244

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

4.50

12.58

2.3

2.0

5.35

5.15

kpa

0.28

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

4.50

12.58

2.3

2.0

9.98

9.92

kpa

0.03

(3036525) Urea [Moles/time] in 24 hour Urine

17.35

12.50

2.4

1.9

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

6.20

12.46

3.6

1.8

1.37

1.38

umol/l

0.03

(3025886) Oxalate [Mass/time] in 24 hour Urine

24.37

12.45

1.2

1.1

28.99

45.66

mg/24h

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

152

810

1.91

12.43

1.3

1.05

3.59

u/ml

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

175

976

1.83

12.42

1.3

3.18

5.83

u/ml

1.26

161

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

308

2.50

12.34

1.9

1.5

378.67

351.50

mu/l

0.20

246

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.92

12.25

1.2

1.1

—

(40765096) Chromosome analysis panel by Banding

123

3.44

12.19

1.2

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

385

2.32

12.09

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

173

972

1.82

12.00

1.3

2.84

5.86

u/ml

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

115

3.50

11.94

1.3

—

(3014271) Vancomycin [Susceptibility]

125

3.39

11.90

3.7

2.8

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

276

1767

1.61

11.85

3.2

3.7

55.01

80.51

u/ml

1.00

266

1710

(3000475) Leukocytes [#/volume] in Synovial fluid

156

854

1.86

11.76

2.0

1.6

16337.01

11183.51

e6/l

0.86

116

599

(3027570) Oxalate [Moles/time] in 24 hour Urine

10.53

11.74

1.8

1.4

316.59

341.57

umol/24h

0.20

(3023199) Leukocytes [#/volume] in Pleural fluid

397

2.27

11.70

1.5

1.4

1729.44

2829.93

e6/l

0.78

279

(3006653) Thiamine [Moles/volume] in Blood

157

3.08

11.68

1.3

1.2

130.60

133.98

nmol/l

0.21

157

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

372

2.31

11.68

2.0

1.6

—

1729.23

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

169

2.98

11.51

1.9

1.4

1.28

1.19

nmol/l

0.23

120

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

215

2.72

11.29

1.3

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

145

3.13

11.24

1.2

1.6

—

(3006245) CD3-CD19+ cells/cells in Blood

115

3.42

11.22

2.2

2.9

7.97

10.67

0.84

107

(3017937) Magnesium [Moles/time] in 24 hour Urine

20.08

11.12

1.4

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

218

2.69

11.00

1.3

1.2

—

(3021788) Differential panel - Synovial fluid

122

632

1.96

10.89

2.0

1.5

—

1.00

—

(3012441) Differential panel - Pleural fluid

340

2.32

10.84

1.5

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

215

2.68

10.75

1.8

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

3.79

10.74

1.5

1.3

11.75

13.79

g/l

0.50

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

171

2.89

10.68

1.3

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

171

2.89

10.68

1.3

1.5

—

(3045788) Cell count panel - Pleural fluid

324

2.34

10.65

1.4

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

161

2.94

10.60

1.0

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

5.43

10.39

2.0

1.6

—

(3005322) IgE [Units/volume] in Serum or Plasma

316

2150

1.51

10.36

1.4

1.3

245.65

228.13

u/ml

0.07

296

1991

(3019150) Specific gravity of Urine by Refractometry

957

7830

1.30

10.30

5.6

4.0

1.02

1.21

kg/l

0.50

685

5113

(3014765) Yersinia sp identified in Stool by Organism specific culture

151

854

1.80

10.29

1.4

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

440

2.12

10.23

1.4

1.3

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

154

2.94

10.17

3.7

4.6

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

150

850

1.80

10.16

1.4

1.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

468

2.08

10.16

1.3

1.1

38.85

1317.31

iu/ml

0.53

102

(42529406) Shigella sp [Presence] in Stool by Culture

151

859

1.79

10.10

1.4

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

141

3.00

9.83

2.6

2.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

148

846

1.78

9.75

2.9

2.2

3983.16

4768.57

u/l

0.11

347

(3044007) Cell count panel - Peritoneal fluid

3.46

9.73

1.7

—

(3000060) B lymphocytes [#/volume] in Blood

3.58

9.64

1.8

2.9

0.29

0.21

e9/l

0.29

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

134

748

1.82

9.56

1.3

1.2

50.37

41.50

u/ml

—

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

4.44

9.54

1.1

1.0

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

216

1375

1.60

9.52

1.6

1.4

26.92

28.58

iu/l

0.27

183

1181

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

3.46

9.45

1.4

1.3

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

150

2.89

9.42

1.0

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

181

1106

1.67

9.39

1.8

1.7

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

343

2.21

9.36

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

305

2.29

9.34

1.2

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

312

2.27

9.29

1.4

1.3

879.07

352.55

u/l

0.60

302

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

136

770

1.79

9.27

1.1

3.73

6.74

eliau/ml

—

(3016018) Differential panel - Cerebral spinal fluid

358

2.17

9.23

1.3

1.5

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

141

2.93

9.22

1.5

1.3

55.80

69.31

—

(3012989) Citrate [Moles/time] in 24 hour Urine

18.63

8.92

1.5

1.3

2.12

1.89

mmol/24h

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

7.44

8.91

4.1

1.7

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

12.54

8.85

3.7

2.7

—

(40768806) Pleura Pathology biopsy report

352

2.15

8.80

1.5

1.6

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

156

2.78

8.79

1.0

1.1

1542.07

1504.26

miu/ml

0.08

156

(3028433) Virus identified in Specimen by Culture

108

3.17

8.76

1.3

1.2

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

8.21

8.56

7.4

4.9

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

364

2.11

8.49

1.1

—

4.59

—

(3007461) Platelets [#/volume] in Blood

3657

35544

1.56

8.47

54.7

22.5

250.45

249.74

e9/l

0.23

3620

34797

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

3.89

8.41

1.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

359

2.11

8.39

1.4

13184.54

57600.97

e6/l

1.22

198

(3024731) MCV [Entitic mean volume] in Red Blood Cells

3657

35550

1.55

8.39

54.4

22.4

92.04

91.21

20.26

3639

35124

(3035941) MCH [Entitic mass]

3657

35551

1.55

8.38

54.4

22.4

30.52

30.36

5.86

3639

35125

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.47

8.36

1.3

1.1

—

(3026361) Erythrocytes [#/volume] in Blood

3657

35554

1.55

8.34

54.6

22.5

4.27

4.49

e12/l

95.36

3613

34682

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

3657

35554

1.55

8.34

55.6

22.9

38.71

40.70

20.93

3638

35110

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

178

2.60

8.33

1.1

0.94

1.14

u/l

2.60

(3010813) Leukocytes [#/volume] in Blood

3657

35556

1.55

8.31

54.7

22.5

7.06

6.67

e9/l

17.14

3614

34672

(3000963) Hemoglobin [Mass/volume] in Blood

3657

35560

1.55

8.26

55.1

22.6

128.78

135.54

g/l

97.44

3639

35148

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

14.48

8.19

3.3

4.3

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

261

2.28

8.02

1.3

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

313

2.16

7.99

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

327

2362

1.42

7.89

2.5

21.94

22.37

au/ml

0.03

235

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

362

2.06

7.85

1.2

24.20

49.43

u/ml

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

258

2.27

7.80

1.3

1.1

—

(4146454) Self-monitoring of blood glucose

318

2.13

7.69

3.4

2.5

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

304

2180

1.43

7.64

1.3

67.21

56.24

au/ml

0.20

162

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

449

1.94

7.62

1.3

1.5

0.33

0.31

nmol/l

0.08

339

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

149

919

1.65

7.52

1.3

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

124

2.84

7.52

1.5

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

330

2408

1.41

7.52

1.9

1.7

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

3.67

7.45

4.4

2.5

4.43

120.09

ug/l

0.98

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

352

2602

1.39

7.43

1.5

1.4

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

337

2.07

7.37

1.8

1.4

110569.67

86513.55

e6/l

0.15

227

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

160

2.58

7.34

1.3

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

247

1717

1.47

7.33

2.7

2.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

3.05

7.30

1.1

80.91

88.94

0.36

(3008536) Aspergillus sp Ab [Presence] in Serum

3.49

7.26

2.9

1.9

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

185

2.45

7.24

1.1

7.65

16.20

nmol/l

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

127

2.77

7.21

1.7

1.3

66.17

63.77

0.14

101

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

100

3.02

7.18

1.1

90.83

88.37

0.07

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

255

2.21

7.15

1.1

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

20.05

7.13

4.9

5.2

409.20

380.60

umol/l

—

(3052592) Norovirus Ag [Presence] in Stool

4.06

7.07

2.1

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

250

2.22

7.06

1.3

1.1

—

(3016244) Insulin [Units/volume] in Serum or Plasma

158

2.55

7.00

3.4

3.3

26.51

23.74

mu/l

0.16

152

(3027456) Digoxin [Moles/volume] in Serum or Plasma

111

646

1.74

6.98

3.6

3.2

0.86

0.80

nmol/l

0.57

519

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

241

3383

0.69

6.97

2.0

3.66

3.50

ratio

1.22

194

2634

(37208534) Antinuclear antibody arbitrary concentration in serum

103

2.93

6.84

1.3

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

256

2.17

6.68

1.3

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

256

2.17

6.68

1.3

1.1

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

316

2.04

6.68

2.1

1.5

21.20

30.20

1.61

189

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

300

2.05

6.45

1.3

1.67

1.53

nmol/l

0.39

268

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

3.51

6.43

1.5

1.6

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

3.21

6.41

1.2

1.3

23.38

26.83

g/l

0.34

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

4.06

6.35

1.1

1.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

421

1.87

6.32

1.3

90.16

47.10

u/ml

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

472

1.82

6.30

1.3

2.86

3.31

u/ml

0.29

210

(3033926) Protein [Mass/volume] in Peritoneal dialysis fluid

18.04

6.26

6.0

2.2

2.19

2.70

g/l

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

133

838

1.61

6.23

1.2

1.1

4.10

4.14

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

252

2.12

6.13

1.2

38.34

36.52

mg/l

0.16

206

(3009466) Valproate [Moles/volume] in Serum or Plasma

404

1.87

6.12

6.1

5.3

341.49

354.20

umol/l

0.31

352

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

239

2.15

6.12

1.2

1.1

269.84

255.73

mg/l

0.24

208

(3033923) Metanephrine [Moles/time] in 24 hour Urine

3.60

6.03

1.1

0.78

0.69

umol/24h

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

3.16

6.01

1.1

1.2

—

(3018333) Ribosomal P Ab [Presence] in Serum

241

2.13

6.00

1.3

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3179

30504

1.24

5.93

5.1

4.1

1.42

1.26

mmol/l

29.62

2892

27820

(3024891) Influenza virus A+B Ag [Presence] in Specimen

126

798

1.60

5.80

1.2

1.1

—

(3034891) Synovial lining cells/cells in Synovial fluid

161

2.37

5.79

2.1

1.4

1.60

4.41

—

(3032057) Clostridioides difficile [Presence] in Stool

3.47

5.72

1.4

1.8

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

246

2.09

5.71

1.3

1.1

—

(3035880) pH of Pleural fluid

170

2.31

5.59

1.4

1.3

7.40

7.41

0.08

112

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

12.88

5.58

1.2

1.4

27.70

45.79

umol/24h

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

515

4187

1.27

5.55

12.0

6.3

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

304

1.96

5.53

1.2

1.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

175

1205

1.47

5.52

1.6

29.23

14.17

u/ml

1.66

266

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

230

2.10

5.48

1.2

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

334

1.90

5.44

4.5

3.8

—

(21494755) Public health laboratory ask at order entry panel

196

2729

0.70

5.43

1.2

1.4

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

174

2474

0.69

5.42

1.7

3.51

3.50

mmol/l

0.06

122

1734

(3043410) Blood group antigens tested for on Red Blood Cells

3.03

5.37

1.9

1.4

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

2.79

5.30

1.8

1.6

22.36

49.42

u/l

0.72

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

2.92

5.29

1.8

1.3

17.27

33.51

1.97

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

131

2.45

5.28

1.1

1.0

—

(44786798) Granulocytes/Leukocytes in Peritoneal dialysis fluid

+∞

5.21

5.8

0.0

—

(3000330) Specific gravity of Urine by Test strip

218

1583

1.40

5.18

5.0

3.2

1.02

ratio

0.08

203

1433

(3001218) Citrate [Mass/time] in 24 hour Urine

13.36

5.07

1.0

1.7

498.62

363.83

mg/24h

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

153

2.30

5.02

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

147

2.32

5.00

1.1

15.18

208.30

ng/l

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

6.89

4.95

3.6

—

(3020393) Adenovirus Ag [Presence] in Stool

3.67

4.92

1.3

1.6

—

(40757373) Influenza virus identified in Isolate

3.22

4.89

1.7

1.4

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

5.21

4.76

1.2

—

361.50

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.41

4.74

2.8

2.0

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.68

4.74

1.0

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

134

905

1.50

4.70

1.3

177.74

216.61

miu/ml

0.57

417

(4212803) Bone marrow aspirate examination

4.68

4.67

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

479

1.68

4.67

1.2

3.03

3.77

u/ml

0.24

179

(3000034) Microalbumin [Mass/volume] in Urine

246

1.96

4.63

4.3

2.7

259.41

17.79

mg/l

1.86

179

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

103

2.53

4.62

1.8

1.4

208.44

119.05

nmol/l

0.35

(3022621) pH of Urine by Test strip

331

2608

1.29

4.60

3.8

2.6

6.03

6.07

0.26

231

1757

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

226

2.00

4.59

1.5

1.4

18.36

12.51

u/l

2.07

218

(3046861) Legionella sp Ag [Presence] in Urine

5.47

4.59

1.1

1.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

153

2.23

4.59

1.1

—

(3006270) Folate [Moles/volume] in Blood

247

1.96

4.58

1.1

372.65

367.96

nmol/l

0.05

218

(3032773) Endomysium IgG Ab [Titer] in Serum

304

1.85

4.56

1.1

—

(3006576) Bicarbonate [Moles/volume] in Blood

2.81

4.54

6.1

5.6

25.07

24.86

mmol/l

0.07

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

10.02

4.52

1.1

—

mmol/l

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

308

1.83

4.39

3.4

2.1

10.57

7.10

umol/l

0.32

225

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.21

4.33

2.8

1.9

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

5.51

4.28

1.1

1.0

—

(3040893) Potassium [Moles/volume] in Capillary blood

11.68

4.27

3.0

1.5

4.47

4.33

mmol/l

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1196

10783

1.16

4.19

5.3

5.5

4.11

3.29

ug/l

0.62

1076

9759

(3013139) Helicobacter pylori Ag [Presence] in Stool

298

2347

1.29

4.17

1.3

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

441

1.67

4.16

2.9

2.3

29.44

21.55

mg/l

0.66

160

(3002619) Bacteria identified in Specimen by Culture

2.67

4.15

1.3

1.2

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

180

2.07

4.14

1.5

1.2

0.54

0.56

ratio

0.17

103

(3042010) Triglyceride [Moles/volume] in Pleural fluid

3.09

4.08

1.2

0.75

2.50

mmol/l

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

188

2.03

4.08

1.2

1.1

1.08

1.06

ratio

0.52

149

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

592

1.57

4.07

1.9

1.8

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

2.76

4.01

1.2

1.1

62.83

75.50

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

2.76

4.01

1.1

67.17

80.85

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

2.94

4.00

9.7

6.9

6.54

4.91

kpa

1.21

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

509

1.60

3.97

1.1

3.58

16.67

au/ml

4.17

120

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

3.13

3.92

1.1

1.2

—

(3028707) Methadone [Presence] in Urine by Screen method

441

1.64

3.91

2.0

2.7

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

520

4396

1.21

3.89

5.6

4.7

32.28

32.54

0.21

380

2837

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

256

1.85

3.84

1.7

2.0

1.97

1.53

u/field

0.39

134

(3026480) Teichoate Ab [Titer] in Serum

5.27

3.82

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.48

3.79

1.0

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

175

2.01

3.68

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

203

1.93

3.67

1.8

1.4

80.67

79.26

umol/l

0.11

203

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

5.64

3.65

1.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

5.64

3.65

2.3

1.6

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.43

3.63

1.7

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.51

3.60

1.1

1.2

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

1107

0.63

3.60

1.1

1.2

1.52

1.54

g/l

0.26

1107

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

3.72

3.58

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3291

32021

1.19

3.55

5.9

4.8

1.41

1.49

mmol/l

20.92

3037

29532

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

111

2.26

3.54

2.7

2.2

45.17

54.34

umol/l

0.43

(3004716) Salmonella sp identified in Stool by Organism specific culture

192

1459

1.33

3.52

1.4

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

3.62

3.49

1.0

2.8

—

(40768793) Breast Pathology biopsy report

120

846

1.43

3.48

1.4

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1047

0.63

3.44

1.1

0.59

0.63

ratio

—

140

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

4.55

3.42

2.0

2.4

27.60

55.12

—

(40768443) Skin Pathology biopsy report

202

1554

1.32

3.41

1.3

1.2

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

2.99

3.41

1.6

1.9

1.49

2.24

mmol/l

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

2.66

3.39

9.7

6.7

5.75

6.00

kpa

0.58

(3044009) aPTT.lupus sensitive (LA screen)

4.08

3.39

1.4

1.2

—

(3036670) Protein [Mass/volume] in Synovial fluid

107

2.25

3.38

1.2

1.3

38.88

39.94

g/l

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

2.58

3.38

1.0

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

114

2.20

3.34

1.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

196

1.90

3.33

1.9

1.7

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

114

804

1.43

3.31

2.3

1.8

210.53

209.86

pmol/l

0.02

100

770

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

128

2.12

3.29

1.1

1.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

162

1.98

3.28

1.7

1.6

2.51

3.85

u/field

0.41

110

(3019174) dRVVT (LA screen)

3.94

3.28

1.4

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.30

3.26

1.0

1.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3307

32239

1.18

3.23

5.9

4.9

4.49

4.69

mmol/l

25.31

3063

29927

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

3.34

3.22

10.6

0.21

0.36

umol/l

1.84

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

3.54

3.19

1.3

1.4

75.00

67.89

0.35

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

3.54

3.19

1.0

—

(4268621) Lupus anticoagulant assay

350

1.64

3.14

2.0

2.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

623

5454

1.17

3.13

1.6

1.5

—

(3011288) Drugs identified in Urine by Screen method Nominal

688

1.45

3.13

4.9

3.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.54

3.12

1.3

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

2.81

3.08

2.1

1.3

16.00

6.05

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.33

3.07

1.1

—

(40758292) HTLV I+II Ab panel - Serum

2.51

3.04

1.6

1.4

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

440

1.56

3.03

1.1

1.2

119.20

114.41

0.52

398

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.26

3.03

1.7

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

300

1.68

3.02

4.9

2.6

13.18

12.69

index

0.13

167

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

401

1.58

3.01

1.1

1.44

2.95

eliau/ml

1.32

177

(44806071) Cardiolipin IgM antibody measurement

3.34

3.01

1.0

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

100

2.21

2.99

1.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

403

1.57

2.96

1.3

1.2

—

(3008898) HLA-B27 [Presence]

144

1081

1.34

2.92

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

101

2.18

2.92

1.0

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

4.10

2.88

1.7

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

463

1.52

2.85

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

3.92

2.77

1.0

2.1

—

(3023410) Appearance of Cerebral spinal fluid

308

1.63

2.76

1.3

1.8

—

(3018291) Platelet Ab [Presence] in Serum

8.34

2.75

1.0

—

(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma

8.34

2.75

2.8

1.7

23.22

31.83

umol/l

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

218

1.75

2.72

1.3

1.2

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

258

1.67

2.63

1.6

24.17

23.16

u/ml

—

(3024869) Neuronal Ab [Presence] in Serum

2.66

2.62

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

3.61

2.57

1.0

1.1

1.71

1.90

umol/24h

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

156

1.87

2.56

1.2

1.1

—

(3013336) Amino acids [Identifier] in Serum or Plasma

7.15

2.55

12.0

2.7

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

135

1.93

2.55

1.0

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

186

1.78

2.52

1.1

1.5

7.67

7.96

ug/l

0.07

168

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.16

2.50

1.1

—

(3042517) Benzodiazepines panel - Urine

3.81

2.46

1.5

3.7

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.13

2.43

1.0

1.3

—

(3014891) Appearance of Pleural fluid

2.90

2.41

1.4

1.5

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.35

2.38

2.0

1.1

1.19

1.18

mmol/l

0.07

(3016879) Cocaine [Presence] in Urine

123

935

1.33

2.36

1.7

2.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

3.64

2.36

1.0

2.1

—

(4195642) Thrombophilia screening test

444

1.47

2.33

1.1

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

453

1.46

2.31

1.2

1.1

3.38

3.53

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.38

2.29

1.4

—

(3035320) C reactive protein [Mass/volume] in Body fluid

238

1.65

2.28

3.9

2.4

40.61

31.26

mg/l

0.61

168

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

4.62

2.27

3.0

1.7

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.75

2.27

1.1

1.0

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3339

32738

1.15

2.27

6.5

5.5

2.58

2.75

mmol/l

23.00

3087

30213

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

134

1.87

2.26

1.0

1.1

96.28

92.37

0.24

103

(3027008) Opiates [Presence] in Urine

132

1021

1.30

2.25

1.7

2.0

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

205

1677

1.23

2.21

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

5.56

2.21

1.0

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

5.56

2.21

1.0

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

131

1016

1.30

2.20

1.7

2.0

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

107

1.97

2.20

1.1

1.0

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.56

2.07

1.2

1.8

—

(3009871) Measles virus Ab [Titer] in Serum

131

1.84

2.07

1.7

4480.00

3960.00

titre

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

5.00

2.07

1.0

—

(3028300) Cannabinoids [Presence] in Urine

131

1027

1.29

2.05

1.7

2.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

103

1.95

2.05

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

105

799

1.32

2.04

1.8

2.1

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

2.40

2.02

1.6

—

(3028717) Thiamine [Mass/volume] in Blood

2.50

2.01

1.2

1.3

65.45

64.23

ug/l

0.04

(3027944) Amphetamines [Presence] in Urine

128

1008

1.28

1.95

1.6

2.0

—

(3022725) Serotonin [Moles/volume] in Serum

4.55

1.94

1.0

1.6

557.40

2181.09

nmol/l

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

4.55

1.94

1.0

1.1

—

(4281824) Cell count and differential, peritoneal fluid

355

1.47

1.92

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

254

1.54

1.81

1.5

1.3

0.34

1.29

u/ml

1.34

148

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

145

1.73

1.81

1.3

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

344

1.46

1.80

1.2

1.3

7.46

7.39

mmol/l

0.06

306

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

3.05

1.80

2.1

1.4

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

208

1.59

1.76

1.1

1.5

—

(3020650) Glucose [Presence] in Urine

139

1.73

1.75

1.9

1.8

0.00

0.02

estimate

0.50

139

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

2.50

1.74

1.1

2.0

—

(40758358) Immune stain study

3.85

1.71

1.0

—

(3020491) Glucose [Moles/volume] in Blood

226

1.55

1.70

2.1

1.9

7.80

6.53

mmol/l

1.13

144

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

111

1.81

1.68

1.7

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

111

1.81

1.68

4.3

1.9

8.19

827.03

pmol/l

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

104

1.83

1.67

1.7

10.57

8.87

ug/l

0.78

104

(4024509) Urine culture

187

1569

1.20

1.64

2.2

1.9

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

2.25

1.63

1.0

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

105

1.81

1.62

1.2

1.3

129.56

492.93

ug/l

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

270

1.49

1.61

1.7

1.6

2.62

4.03

ug/l

0.61

227

(3024263) Appearance of Synovial fluid

174

1.61

1.60

1.7

1.6

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

2.33

1.58

8.2

7.1

11.30

10.32

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

3.00

1.58

1.2

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.20

1.56

2.1

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.20

1.56

2.0

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.20

1.56

2.1

1.2

—

(1002224) Polysomnography panel

170

1423

1.20

1.55

1.1

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

2627

26913

0.93

1.48

44.3

19.0

331.25

332.21

g/l

5.58

2618

26746

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.44

1.47

1.1

1.0

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

109

1.75

1.46

1.5

1.3

61.11

55.72

0.27

(3033099) Centromere Ab [Titer] in Serum

1.88

1.44

1.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

3.13

1.44

1.2

1.0

230.60

282.38

nmol/l

—

(3022475) Manganese [Moles/volume] in Blood

3.13

1.44

1.2

1.1

0.16

umol/l

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

130

1070

1.22

1.42

1.9

1.8

4.38

4.57

mg/l

0.06

113

771

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

1.90

1.39

4.6

8.8

60.00

69.83

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

502

1.32

1.38

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

385

0.65

1.38

1.5

1.8

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.20

1.37

1.2

1.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

461

1.33

1.34

1.3

1.2

—

(3025577) Chromium [Mass/volume] in Blood

224

1.48

1.33

2.1

1.96

2.25

ug/l

0.38

185

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

137

1.61

1.29

2.1

212.88

100.18

ug/min

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

421

1.34

1.28

1.1

3.16

5.20

u/ml

0.39

192

(3041672) Baker's yeast Ab [Presence] in Serum

2.63

1.21

1.2

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.31

1.18

2.8

3.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1460

14034

1.06

1.13

2.1

1.9

1.46

1.32

mmol/l

6.64

1206

11613

(3005033) Fetal Nuchal fold Thickness US

401

0.70

1.12

1.5

1.28

1.27

0.03

292

(3050794) Legionella sp Ab [Presence] in Serum

2.38

1.09

1.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

152

1.52

1.08

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.65

1.06

1.2

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.65

1.06

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.65

1.06

1.2

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

1.65

1.06

1.2

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.65

1.06

1.2

1.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

408

0.71

1.06

1.4

1.5

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

669

1.23

1.04

1.1

0.79

1.94

u/ml

2.24

381

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.96

1.03

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

417

0.72

1.03

1.5

1.6

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.64

1.03

1.8

1.3

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.84

1.02

1.2

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

0.97

0.0

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

117

0.51

0.94

1.5

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

912

0.83

0.87

1.4

1.6

1041.44

1009.79

mu/l

0.08

760

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.00

0.87

1.0

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

459

1.25

0.86

1.1

2.07

3.96

u/ml

0.83

232

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.94

0.84

1.2

1.1

0.02

u/ml

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

488

1.23

0.83

1.5

1.6

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

115

1322

0.87

0.80

1.9

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.82

0.79

1.5

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

0.00

0.79

0.0

1.0

—

4.21

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

638

1.20

0.78

5.1

3.4

27.03

27.75

mg/l

0.06

431

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

1.67

0.78

1.5

3.9

103.20

103.12

ng/l

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

284

3090

0.91

0.78

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

141

1589

0.88

0.75

1.9

2.0

—

(44806420) Estimation of glomerular filtration rate

352

1.25

0.73

3.0

2.3

—

(3039443) Prostate specific Ag panel - Serum or Plasma

643

0.82

0.71

1.3

1.7

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

194

1.34

0.71

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.92

0.70

1.0

—

(4198724) Urine methamphetamine measurement

110

1.46

0.68

1.4

1.9

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.49

0.66

1.6

1.8

—

(3001729) Color of Synovial fluid

1.79

0.66

1.4

1.7

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

237

0.72

0.66

1.4

223.99

217.11

pmol/l

0.04

237

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

316

0.76

0.65

1.2

1.6

64.15

56.60

ug/l

0.51

316

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

163

1.35

0.64

1.1

1.3

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.73

0.64

1.0

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

491

0.81

0.62

1.4

1.5

1.00

0.94

ratio

0.32

311

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

491

0.81

0.62

1.4

1.5

1.05

1.22

ratio

0.82

311

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

491

0.81

0.62

1.4

1.5

1.42

1.15

ratio

0.36

311

(3029075) Extractable nuclear Ab panel - Serum

199

1.31

0.62

1.2

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.67

0.61

3.0

2.1

0.20

0.73

u/field

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

983

0.87

0.60

1.4

1.5

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.1

—

0.60

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.57

0.60

3.5

2.2

13.89

18.85

umol/l

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

246

1.26

0.58

1.0

890.18

743.94

ng/l

0.65

159

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

485

0.82

0.57

1.4

1.5

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

158

1.33

0.57

1.0

1.1

0.16

4.78

u/ml

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.67

0.56

1.0

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

249

1.25

0.53

1.0

33.69

45.95

ng/l

1.83

165

(40765089) Chromosome analysis panel - Blood by G-banded

1.49

0.53

1.0

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

1.54

0.53

1.0

1.8

10.55

4.07

nmol/l

—

(1761868) Lipid panel - Serum or Plasma

1213

12450

0.96

0.52

3.7

3.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.56

0.49

1.0

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.46

0.46

1.6

1.4

—

(40768800) Prostate Pathology biopsy report

714

1.12

0.44

1.3

1.2

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

247

1.22

0.44

1.0

343.95

337.74

ng/l

0.04

165

(3008401) Mugwort IgE Ab [Units/volume] in Serum

546

1.14

0.42

1.1

0.98

1.14

u/ml

0.10

263

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

1.56

0.42

1.4

2.3

1.22

1.49

mg/l

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.40

0.0

1.0

—

(4034850) Laboratory test

114

1046

1.09

0.39

14.3

9.4

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.39

0.0

10.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

400

1.15

0.39

1.1

0.06

0.30

u/ml

1.74

149

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.36

0.38

1.0

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

430

0.86

0.37

1.4

1.6

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

887

8649

1.03

0.37

4.4

4.5

22.49

21.76

0.63

445

4419

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.35

0.37

1.4

1.1

96.00

84.76

titre

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

0.66

0.35

3.4

1.7

2.14

1.90

ug/l

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

1.31

0.35

2.9

2.6

32.50

29.55

umol/l

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

134

0.75

0.34

1.1

1.2

13.90

10.41

mm/h

—

134

(3006462) Nitrate [Presence] in Urine

163

1.23

0.34

4.9

3.5

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.35

0.31

2.4

3.4

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

561

1.11

0.31

1.1

2.08

3.94

u/ml

1.13

313

(4015189) Microbial culture of sputum

1.31

0.30

1.9

2.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

271

2601

1.05

0.28

2.2

2.0

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

531

0.90

0.26

1.4

1.6

70.64

61.01

ug/l

0.42

448

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

305

1.12

0.21

1.3

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.0

—

4.40

—

(3020874) Milk IgE Ab [Units/volume] in Serum

182

1.15

0.21

1.0

1.1

0.42

1.62

u/ml

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

241

0.87

0.21

1.3

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.16

0.21

1.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

177

0.85

0.21

1.4

1.2

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

295

2862

1.03

0.20

2.4

2.1

—

(3051101) Glucose [Moles/volume] in Cord blood

1.15

0.19

2.8

7.5

14.83

8.12

mmol/l

—

(4094501) Cardiovascular stress test using bicycle ergometer

912

1.05

0.18

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

535

1.07

0.16

1.1

2.66

1.59

u/ml

0.38

283

(4211845) Urine protein measurement

178

1.12

0.15

4.9

3.4

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

132

1.14

0.13

1.1

9.80

6.75

u/ml

—

(3003740) Influenza virus B Ag [Presence] in Specimen

550

1.06

0.12

1.3

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

590

0.95

0.12

1.4

1.5

—

(44813793) Dust mix specific IgE antibody measurement

231

1.08

0.10

1.1

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.11

0.09

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

271

1.07

0.09

1.0

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.09

0.09

1.0

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

106

1090

0.97

0.09

1.5

1.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

548

1.04

0.08

1.3

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

655

6501

1.01

0.07

3.2

3.3

0.89

0.77

ug/l

0.96

447

4291

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

307

1.04

0.05

1.3

1.5

—

(3034426) Prothrombin time (PT)

102

1.08

0.03

1.1

1.3

30.09

27.95

0.53

102

(3001019) Free T4 and TSH panel - Serum or Plasma

149

1476

1.01

0.02

1.7

—

(3025130) Human papilloma virus identified in Specimen

442

1.02

0.01

1.4

1.8

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

214

1.03

0.00

1.1

1.2

13.79

18.39

u/ml

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

142

0.99

0.00

1.9

2.0

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

175

1.03

0.00

1.0

1.1

0.40

1.23

u/ml

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

486

4863

1.00

0.00

1.4

1.5

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

2.0

—

276.44

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

3320.00

—

(3009992) Blasts/cells in Bone marrow

0.00

-0.00

0.0

1.4

—

6.40

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

1.47

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3022670) pH of Venous cord blood

0.00

-0.00

0.0

1.0

—

(3036180) Methadone [Presence] in Urine

0.00

-0.00

0.0

3.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

-0.00

0.0

1.2

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(4133840) Spirometry

0.91

-0.00

1.1

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.34

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

-0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.96

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint E4_MINERAL_MET and mortality.

Females

Parameter	HR [95% CI]	p-value
E4_MINERAL_MET	2.617 [2.34, 2.93]	< 0.001
Birth year	0.996 [0.99, 1.0]	0.322

During the follow-up period (1.1.1998 — 31.12.2019), 3027 out of 8828 females with E4_MINERAL_MET died.

Males

Parameter	HR [95% CI]	p-value
E4_MINERAL_MET	3.794 [3.25, 4.43]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.009

During the follow-up period (1.1.1998 — 31.12.2019), 2295 out of 5987 males with E4_MINERAL_MET died.

Mortality risk

Mortality risk for people of age

years, who have E4_MINERAL_MET.

N-year risk	Females	Males
1	0.258%	0.65%
5	1.569%	4.37%
10	4.004%	10.145%
15	7.557%	18.812%
20	12.678%	31.367%

Relationships between endpoints

↥

Index endpoint: E4_MINERAL_MET – Disorders of mineral metabolism

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Disorders of mineral metabolism

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints